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Cell membranes are composed of a great diversity of lipids and proteins. The lipid raft
concept suggests that instead of a homogeneous distribution of the membrane components,
they are laterally segregated into domains of compositional and functional diversities. The
rafts are thought to be functional membrane domains rich in saturated lipids and choles-
terol, serving as platforms for signaling and lateral sorting of membrane components.
G protein–coupled receptors (GPCRs) are versatile signaling machines that control a
large variety of physiological processes. For example, the cyclic adenosine monophosphate
(cAMP) signaling pathway used for cellular communication is triggered by GPCRs. Many
signaling components in the cAMP pathway have been associated to rafts. The compart-
mentalization of signaling components to small regions would enable a rapid and accurate
activation of the signaling pathways. It is not clear, however, whether GPCRs themselves
reside in raft-like domains. GPCRs constitute the largest class of integral membrane pro-
teins and are major drug targets. Therefore, further knowledge on their location in cell
membranes could be significant in understanding the signaling processes they trigger and
furthermore in the development of drugs acting on them.
The aim of this work is to investigate the partitioning of the β2-adrenergic receptor, a
characteristic GPCR, in a phase segregated membrane by molecular dynamics simulations,
and thus to find out the receptor’s preference for different domains. This is done by
systematically placing the receptor in different membrane domains, such as liquid-ordered
(Lo) or liquid-disordered (Ld) domains, or in a random distribution of a phase separating
lipid mixture. According to the results, the receptor does not completely reside either in
the raft-like Lo domain or in the Ld domain. The receptor repeatedly seeks to the Lo/Ld
boundary irrespective of the initial location, and creates a special environment around it
consisting of cholesterol and Ld-associated unsaturated lipids.
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Solukalvo koostuu laajasta kirjosta erilaisia lipidejä ja proteiineja. Lipidilautta-
teoria ehdottaa, että näiden komponenttien satunnaisen jakautumisen sijaan ne
jakautuisivatkin solukalvossa lateraalisesti koostumukseltaan ja toiminnaltaan eri-
laisiin faaseihin. Lipidilauttojen uskotaan olevan runsaasti tyydyttyneitä lipidejä ja
kolesterolia sisältäviä toiminnallisia alueita, jotka muodostavat alustan solukalvokom-
ponenttien viestinvälitykselle.
G-proteiinikytkentäiset reseptorit osallistuvat moniin fysiologisiin prosesseihin ja
ovat tärkeitä solun viestinvälityksessä. Ne aktivoivat adenosiinimonofosfaattiväylän,
jonka monien viestinvälityskomponenttien uskotaan sijaitsevat lipidilautoilla. Kom-
ponenttien keskittyminen juuri lipidilauttojen kaltaisille pienille alueille mahdollis-
taisi viestinvälityspolkujen nopean ja tarkan aktivoitumisen. On kuitenkin epä-
selvää, sijaitsevatko itse G-proteiinikytkentäiset reseptorit lipidilauttojen kaltaisilla
alueilla. Suuri osa olemassa olevista lääkkeistä toimii G-proteiinikytkentäisten resep-
torien kautta, ja siksi lisätieto niiden sijainnista solukalvoissa olisi arvokasta niiden
aktivoimien prosessien ymmärtämisessä ja edelleen niiden kautta toimivien lääkkei-
den kehityksessä.
Tämän työn tarkoituksena on tutkia molekyylidynamiikkasimulaatioiden avulla
β2-adrenergisen reseptorin, tyypillisen G-proteiinikytkentäisen reseptorin partitioi-
tumista faasijakautuneessa kalvossa. Ongelmaa lähestytään sijoittamalla reseptori
systemaattisesti erilaisiin faaseihin, kuten järjestyneisiin ja epäjärjestyneisiin alueisiin,
sekä satunnaisesta lipidien jakaumasta muodostuviin lipidikalvoihin. Saatujen tu-
losten perusteella reseptori ei sijaitse täysin kummassakaan faasissa, vaan sen sijaan
hakeutuu toistuvasti näiden kahden faasin rajalle alkusijainnistaan riippumatta,
muodostaen ympärilleen erityisen kolesterolista ja tyydyttymättömistä lipideistä
muodostuvan ympäristön.
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11. INTRODUCTION
The world is made up of atoms: the plants, the rivers, the buildings and clothes, as
well as our bodies are built from them. Many vitally important and scientifically
interesting processes occur on the level of atoms, at the length scale of nanometers.
Experimental research of nanoscale processes is challenging due to their small size
and short duration, yet there are multiple research fields that are focused on atomic
scale phenomena. Designing new materials and development of drugs, for example,
require accurate knowledge of the physical properties that are too fast for human
eye or beyond the limits of the current measurement devices. One solution to study
systems on nanoscale is to use molecular simulations by describing complex chemical
systems in terms of atomic models.
The molecular dynamics (MD) simulation technique is based on classical me-
chanics and provides a method for modeling nanoscale systems. It is a popular and
powerful tool in the study of biological processes, such as membrane receptor me-
diated signal transduction. Several diseases are caused by disorders in membrane
receptor function and can be controlled by drugs acting on the receptors, which has
boosted the research of receptors and their function. The field is constantly develop-
ing; the computational power is growing, the methodologies are improving, and new
high-resolution structures of membrane proteins are being resolved by X-ray crys-
tallography. This has allowed the simulation of many structurally known membrane
proteins in their native environment for durations of several microseconds. Due to
the ability of MD simulation to reach atomic level description not accessible for most
of the experimental techniques, the understanding of membrane protein function has
taken major steps forward. MD simulations can reveal the dynamic behavior hid-
den in the static structures. Currently, a typical state-of-the-art simulation system
includes several membrane proteins embedded to a patch of a lipid bilayer, allowing
the investigation of lipid-lipid and protein-lipid interaction processes.
Cell membranes are formed of a large diversity of lipids and proteins that are de-
signed to perform functions essential for the cell. Instead of being structurally homol-
ogous, the membrane is believed to control these functions by laterally segregating
its components into lateral domains. In the study of model membranes, cholesterol–
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containing lipid mixtures of unsaturated and saturated lipids are known to display
phase coexistence over a broad range of compositions and temperatures [1, 2]. The
lipids separate into a thicker, highly ordered, cholesterol–rich liquid-ordered (Lo)
phase and into a thinner, more mobile, cholesterol–poor liquid-disordered (Ld) phase.
The phase coexistence has been observed in studies of model membranes consisting
of synthetic lipids [3–5], however it is debated whether they exist in live cell mem-
branes since they are optically unresolvable. The lipid raft hypothesis proposes that
these lipid domains are important for cellular function, such as signaling, trafficking,
and lateral sorting of membrane components [6].
The G protein–coupled receptors (GPCRs) are important signal-mediators in
cell membranes and form the largest family of human integral membrane proteins
with over 800 members [7]. They are involved in a wide range of physiological
processes related to several diseases, which has made them an attractive target for
the development of drugs. Currently it is estimated that 30-50 % of the marketed
drugs act on GPCRs [8], for which reason the studies of the GPCRs’ structure,
function, and regulation are at the forefront of the research today. The importance
of the GPCR–related research was highlighted by the Nobel Prize awarded in 2012
for the discovery of the X–ray structure of the β2–adrenergic receptor (β2AR)–Gs
protein complex [9].
GPCRs trigger the cyclic adenosine monophosphate (cAMP) signaling pathway
used for cellular communication. Many components in the cAMP pathway have
been associated to rafts [10]. There are also signs of activity–dependent partitioning
of some GPCRs and G proteins into domains [11, 12]. GPCRs are characterized
by rapid activation of signaling pathways, and the compartmentalization of sig-
naling components to specific domains would enable the activation of the pathways
more rapidly and with higher fidelity than in case all signaling components were ran-
domly distributed along the membrane. Thus, it has been suggested that membrane
domains would serve as a platform in the formation of GPCR-involving signaling
complexes [13–15].
It remains unclear, however, whether the GPCRs reside in any specific membrane
domain, since the studies investigating this topic have given contradictory results.
GPCRs are widely associated with cholesterol [16–18], which implies that they would
prefer raft-like domains enriched with cholesterol. On the contrary, some GPCRs
have been found to prefer the Ld phase and the proximity of lipids they are comprised
of [19–21]. The objective of this study is to find out the preference of β2AR for
different membrane domains. To this end, we studied the partitioning of β2AR in a
1. Introduction 3
highly phase separable model bilayer by MD simulations. β2AR is one of the best
characterized GPCRs with both its inactive [16] and active [9] crystal structures
determined. It is expressed in pulmonary and cardiac myocyte tissue [12, 22] and
important in the treatment of respiratory and heart diseases, such as asthma and
hypertension [23, 24]. The knowledge of its function, regulation, and response is
therefore of great importance.
Unfortunately, consideration of the phase segregation of lipids is currently chal-
lenging for atomistic MD simulations. This problem can be defeated by simplified
coarse-grained models that enable studying of biomolecular processes that involve
greater length scales and durations of tens of microseconds, which cover the lipid
phase separation process. For the purpose of studying the partitioning of β2AR in
a phase separated bilayer, in this thesis a total of 22 coarse-grained systems were
simulated for 10 µs each. To prevent initially placing the protein in a biased loca-
tion in the membrane, the protein was let to adjust its location without control by
initially placing it in different environments; in the Lo phase, in the Ld phase, and in
a random lipid distribution. Additionally, two atomistic systems were simulated for
2 µs each in order to validate the results obtained in the coarse-grained simulations.
This thesis is divided into six chapters. The following chapter covers the bio-
logical background of the topics discussed in this thesis, such as lateral domains
in membranes and the importance of GPCRs. The third chapter focuses on the
methodological background describing the basics of molecular dynamics. The ap-
proach to the objective of this study is described in the fourth chapter, in which the
simulation systems and the force field parameters employed are introduced along
with the analysis methods. The results obtained from the simulations are presented
and discussed in chapter five, and finally the conclusions drawn from this study are
presented in chapter six.
42. BIOLOGICAL BACKGROUND
In this chapter the biological background of this thesis is presented. The structure
of the cell membrane is briefly presented to start with. We now discuss how the
concept of functional domains in cell membranes has modified the early fluid mosaic
model of the cell membrane and is presented next, followed by a description of
receptor proteins, which are important signaling molecules in membranes. Finally, a
significant family of transmembrane receptor proteins, G protein–coupled receptors,
is introduced along with some highlights of the β2-adrenergic receptor, which is
among the best-characterized GPCRs and the receptor used in the current study.
2.1 Structure of Cell Membrane
The cell membrane is crucial for the function of cells, since it separates the interior
of the cell from the outside environment and thus protects the cell. In addition, the
membrane prevents the contents from escaping and determines the molecules that
can pass through it: it allows the nutrients to enter and the waste products to leave.
When a cell is growing or changing, the membrane will change along it by creating
a new membrane or by restructuring the existing one to make sure that there are
no holes in the surface. It is vitally important for a cell to have a membrane since
it could not survive or grow without it.
One of the earliest models of the structure of the cell membrane is based on the
fluid mosaic model proposed by S.J. Singer and G.L. Nicolson in 1972 [25]. Many
other membrane models have been proposed as well over time, but the general idea
of the fluid mosaic model still remains as the best characterization of the structure
and function of the plasma membrane. The fluid mosaic model states that the
plasma membrane is a mosaic of different components, and that these components
move laterally in the membrane making its character fluid-like in two dimensions [25].
The membrane components include different kinds of lipids and proteins that diffuse
easily and serve important functions.
Over thousands of different kinds of lipids exist in cell membranes, such as glyc-
erophospholipids, sphingolipids, and sterols [27]. These different types of lipids all
share a key feature: they are dual-loving molecules [26]. Lipids have hydrophilic
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Figure 2.1: (A) An electron micrograph of human red blood cell plasma membrane, seen
in cross section. (B and C) Schematic drawings of the lipid bilayer, lipids are shown in red
and proteins in green [26].
head groups that prefer to stay in contact with an aqueous environment, and hy-
drophobic tails that repel water. This amphiphilic nature allows lipids to form the
bilayer structure of a membrane, where the head groups face water from both sides
of the membrane and tails stay inside the bilayer, away from water [26]. In addi-
tion to acting as membrane components, lipids are important, e.g., in signaling and
energy storage [27].
Proteins form another major component in plasma membranes. They have impor-
tant functions such as transporting nutrients across a bilayer, anchoring a membrane
to macromolecules on either side, receiving and relaying signals, or working as en-
zymes to catalyze reactions [26]. Proteins consist of chains of amino acid residues
whose sequence varies with different proteins [26]. Membrane proteins can be di-
vided into integral membrane proteins, that are embedded to the bilayer, and to
peripheral membrane proteins, that rest on the membrane surface by attaching to
the bilayer or to an integral membrane protein [28]. In Fig. 2.1 the basic structure
of the membrane is described by the fluid mosaic model: a lipid bilayer with embed-
ded proteins. The mass ratio of proteins and lipids in the membrane composition
can vary with cell type from ∼20:80 in myelin to ∼75:25 in mitochondrial inner
membrane [28].
In addition to lipids and proteins, also carbohydrates are important components
of plasma membranes. They prefer to stay on the outer leaflet of the plasma mem-
brane, where they are bound to proteins forming glycoproteins or to lipids forming
glycolipids [29]. Carbohydrates can form special sites on the membrane surface that
2.2. Lateral Domains Might Play Essential Roles in Membranes 6
helps the cells recognize each other. This phenomenon is important for example for
the immune system to function.
2.2 Lateral Domains Might Play Essential Roles in Mem-
branes
The emphasis of the early fluid mosaic model was in the free lateral diffusion of lipids
and proteins in the membrane, thus implying random order at least at long range,
although the existence of small range order was not denied [25]. In 1982 Karnovsky
et al. validated a theory of lipids organizing into lateral domains of functional and
structural significance [30]. The formation of the domains was suggested to be driven
by lateral phase separation of membrane components into liquid and gel phases, and
cholesterol was found to play an important role in the domain formation [31,32]. The
concept of functional domains, called lipid rafts, was developed further proposing
the rafts to be enriched with glycolipids, sphingolipids, and cholesterol present in
cell membranes [33], and that the rafts serve as important platforms in the sorting
of several membrane proteins and in the formation of signaling complexes [6].
The lipid rafts are currently considered as functional, small, dynamic, and or-
dered microdomains ranging from 10 to 200 nm in size, enriched with cholesterol
and sphingolipids and having lifetimes in the range of microseconds to millisec-
onds [34–40]. The rafts are formed by the phase separation of liquid bilayers [41].
The lipid separation into two macroscopic phases, to a thicker, liquid-ordered (Lo)
domain (raft–like) enriched with cholesterol, and to a thinner liquid-disordered (Ld)
domain, has been found to occur in some synthetic bilayers composing of a ternary
mixture of cholesterol, fully saturated lipids, and unsaturated lipids [42]. The phase
separation is proposed to be highly cholesterol-dependent since cholesterol rings are
planar and therefore prefer interaction with straight, saturated lipid chains over
unsaturated lipid chains that are more bulky [43]. The membrane plane is thus
physically segregated into the Ld phase, characterized by high mobility and disor-
dered lipid chains, and to Lo phase, enriched with cholesterol that has an ordering
effect on the lipid chains and thus slows down the lateral mobility and increases the
thickness of the domain [44]. A schematic figure of the phases is shown in Fig. 2.2.
The two liquid phases only coexist at certain temperature ranges and lipid ratios.
A phase diagram with a highlighted phase coexistence region is shown in Fig. 2.3.
Caveolae are a subclass of lipid rafts containing a protein from the caveolin family,
in addition to being enriched with cholesterol and sphingolipids [46]. The structure
of caveolae was identified by electron microscopy in 1950s to be an ∼100 nm invagi-
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Figure 2.2: A shematic illustration of a lipid bilayer showing phase coexistence. The
liquid-ordered domains are enriched with cholesterol (blue), being thicker and more ordered
than the liquid-disordered domain. The transmembrane proteins locate to the membrane
in such a way that the hydrophobic regions match. They might be targeted to the thicker
Lo regions due to the hydrophobic matching or for example due to palmitoylation. The
figure is modified from reference [45].
nation in the plasma membrane instead of being planar [47,48]. Caveolin stabilizes
the structure of caveolae [49, 50], and contains a scaffolding region that contributes
to binding of the protein into a membrane. Caveolin proteins insert to phosphatidyl-
choline (PC) membranes in a manner that is highly cholesterol dependent [51]. Many
membrane proteins participating in cell signaling have been found present in lipid
rafts and caveolae, and therefore these regions are thought to regulate many kinds
of cellular activities [52, 53], such as endocytosis, exocytosis, transcytosis, nutrient
transport, viral entry and budding, and also receptor and ion channel expression,
activation and desensitization [54–58]. According to the caveolin signaling hypothe-
sis, the interaction of signaling proteins with the caveolin scaffolding domain alters
the signal transduction partners by inhibiting the basal state signaling and facilitat-
ing the interaction of components upon activation of the signaling pathway due to
co-localization in caveolae [10].
The concept of lipid rafts has been controversially argued [60–64], since rafts
are experimentally difficult to observe unambigously in vivo with current tech-
niques. Rafts have been widely studied by isolating them as detergent-resistant
membranes (DRMs) from cells, and these DRMs were thought to reflect the actual
lipid-protein assemblies in living cells [6]. This resulted in studying and categoriza-
tion of membrane proteins into raft and non-raft proteins, based on their detergent-
solubility [65], however it was found that the group of proteins isolated in DRMs
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Figure 2.3: A phase diagram of a micron–scale liquid immiscibility region in GUVs. The
liquid–liquid coexistence region at 25 °C is shown in gray inside the triangle–graph. Below
the phase diagram are the fluorecence micrographs of GUVs studied by nuclear magnetic
resonance (NMR), that show phase coexistence with different DOPC:DPPC lipid ratios:
2:1 (left), 1:1 (center) and 1:2 (right), all mixed with 30 mol-% of cholesterol. The scale
bars are 20 µm. The graph is read as follows: the right face of the graph shows the mass
fraction of cholesterol, left face shows the mass fraction of DOPC and bottom face indicates
the mass fraction of DPPC in the membrane. For the ratio of DOPC:DPPC:CHOL being
0.23:0.47:0.30 in the left, lines can be drawn from those points in the sides towards the
center of the triangle (shown in cyan). The cross point of the lines shows the phase of the
lipid mixture, for example in this case two liquid phases are present. Other possible phases
outside this region are not shown in the graph. The figure is modified from reference [59].
depended on the detergent and conditions used [66]. It was also shown that some
detergents used could grow or even create ordered domains in an initially homoge-
neous membrane [67], and thus DRM experiments could not be considered valid for
the prediction of protein or lipid composition in the assumed domains in live cell
membranes [62].
The lipid phase separation was found to occur in synthetic model systems, so
called giant unilamillar vesicles (GUVs), yielding more pronounced phase separation,
the more pronounced differences there were between the properties of the lipids [3].
In Fig. 2.3 a confocal fluorecence microscopy figure of the phase coexistence on a
GUV is shown. There is evidence that the phases could coexist in cell membranes as
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well [68–70]. The plasma membrane of a live cell does indeed contain lipids necessary
for the phase separation to occur. However, the conditions in live cell membranes are
much more complex than in synthetic model membranes. Live plasma membranes
consist of many different lipid species [71] than the three types needed for the Lo/Ld
phase coexistence. In addition, a major amount of the membrane area is occupied
by proteins that interact with the lipids [72]. The proteins have even been found
to destabilize the phase separation [73]. Also the human body temperature sets
limits to the phase co-existence, at least optically resolvable domains are rare at
temperatures that high [74]. As a consequence to this complexity, the existence
of rafts in synthetic membranes does not necessarily signify their existence in live
cells, despite the evidence of existing Lo and Ld domains and proteins prefering one
domain over the other. On the other hand, the assumption of rafts not existing is
not more justified either.
2.3 Receptors Mediate Signals and Interact with Lipids in the
Membrane
Membrane receptors can be found on the surface of the cell, mediating information
from the exterior of the cell to the interior of it by triggering a response upon activa-
tion. Depending on type, receptors’ information transfer can be triggered by binding
of signaling molecules, called ligands, or they can respond to light, odors, or change
in the oxygen concentration [28]. A given ligand can trigger different responses de-
pending on the receptor to which it binds. On the other hand, receptors are not
ligand-specific, since many ligands can bind to a certain receptor [75]. Different
receptor families exist, such as ion channel receptors, enzyme-linked receptors, and
G protein-coupled receptors [26]. Cells contain multiple receptors of different kinds
depending on cell type.
Transmembrane receptors have an extracellular domain receiving the signal, a
hydrophobic region spanning the membrane, and an intracellular domain relaying
the signal. Once a receptor receives a signal, it activates, and the receptor goes
through a conformational change that might enable the intracellular domain to bind
an effector protein or open an ion channel. Most of the existing drugs are targeted to
receptors to modify their activity, either by activating the receptor, or by preventing
its activation in order to obtain the desired response.
Many membrane proteins have been shown to require specific lipids for stabi-
lization and for activity [76–78]. It has been suggested that the variation of the
composition of a lipid bilayer might affect the function and structure of membrane
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proteins [79]. Lipids might affect the protein function either by interacting directly
with the protein, or via indirect interaction by changing the membrane physical
properties [80, 81]. Hydrophobic or hydrophilic lipid-protein interactions have been
found to result in a slower lipid exchange near the protein surface, and therefore
proteins are surrounded by a shell of annular lipids that behave differently than the
lipids further from the protein [82]. The movement and order parameter of these
boundary lipids might be affected up to 3-4 nm away from the protein surface [83].
It has been estimated that 50-100 lipid molecules diffuse as a dynamic complex with
the protein they are surrounding [83].
The preference of proteins for specific lipid domains can be tightly regulated by
several mechanisms. In order to form a stable membrane structure, transmembrane
proteins are adjusted to a membrane by hydrophobic matching, which means that
the hydrophobic thickness of the protein matches with the hydrophobic thickness
of the membrane [84–87]. If the hydrophobic regions are mismatched, the lipids
near the membrane protein will adapt to the hydrophobic part of the protein by
elastic distortion to minimize energy [84, 88]. The concept of hydrophobic match-
ing has been proposed to be important in the formation of lipid rafts and for the
selective partitioning of transmembrane proteins into specific lipid domains, where
hydrophobic thickness of the domain matches with the hydrophobic part of the pro-
tein [85, 89]. Many receptors have been found present in lipid rafts, such as some
epidermal growth factor receptors, platelet-derived growth factor receptors, and en-
dothelin receptors [38]. Thus the signaling could be altered by the changes in the
partitioning of molecules between raft and nonraft domains in the membrane. Also
palmitoylation, covalent attachment of fatty acids to some residues of membrane
proteins, has been reported to regulate the affinity of integral membrane proteins
for rafts [90]. Some peripheral membrane proteins, such as a nonreceptor tyrosine
kinase, has been found to be reversibly palmitoylated, losing the raft association
after depalmitoylation [91]. It was also suggested that the affinity of proteins for
certain domains is defined by lipid shells surrounding them, causing the protein-
lipid complex to target domains consisting of lipids compatible with the lipids of the
shell [82].
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2.4 G Protein-Coupled Receptors – An Important Receptor
Superfamily
The family of GPCRs consists of around 800 members [7] and makes up the largest
family of membrane proteins. GPCRs are involved in a wide range of physiological
processes related to several diseases, i.e., metabolic [92–94], mental [95,96], immuno-
logical [97,98], inflammatory [99], cardiovascular [97,100], and senses [101] disorders,
as well as cancer [102]. The variety of physiological processes involving GPCRs has
made them an attractive target for the development of drugs, approximately 30-50
% of the current drugs acting on GPCRs [103, 104], yet on only a small fraction of
them [105].
GPCRs share a charasteristic structure consisting of seven transmembrane α-
helices connected to each other with three extracellular and three intracellular loops,
and an eighth short helix parallel to the membrane intracellular surface. The amino
acid chain starts from an N-terminus outside the cell and ends with a C-terminus
inside it. The extracellular domain of the receptor acts as a ligand binding site
whereas the intracellular domain binds the guanine nucleotide-binding protein (G
protein). Despite the common core in all GPCRs, the intracellular and extracellular
regions are different in structure, length, and sequence, enabling then to respond
to a wide variety of ligands, such as ions, amines, odorants, lipids, peptides, pro-
teins, nucleotides, and photons [106]. The first classification method of GPCRs
divided them into six classes from A to F based on the sequence homology: Class
A (rhodopsin-like), B (secretin receptor family), C (metabotropic glutamate), D
(fungal mating pheromone receptors), E (cyclic AMP receptors) and F (frizzled
or smoothened) [107]. An alternative classification of GPCRs has been suggested,
called GRAFS, and it divides GPCRs into five main families according to their
evolutionary origin: glutamite, rhodopsin, adhesion, frizzled, and secretin, of which
rhodopsin forms the largest group [108].
Once a GPCR is activated, it binds specific G proteins, of which most are het-
erotrimers consisting of Gα, Gβ, and Gγ subunits. The Gα and Gγ subunits are
anchored to the membrane through a lipid chain. The Gα subunit consists of an
α-helical domain and of a Ras domain, which is a GTPase, meaning that it can bind
and hydrolyze guoanosine triphosphate (GTP). In an inactive state the subunit α
binds guanosine diphosphate (GDP), and activates once it is replaced by GTP. Ac-
tivation proceeds as follows: binding of ligand induces a conformational change in
the receptor, which further on enables the binding of G protein in the intracellular
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(a) (b)
Figure 2.4: The activation process of GPCRs. (a) The inactive state of both the receptor
and the G protein. (b) The binding of ligand induces conformational changes in the
receptor, that enables the binding of the G protein. The Gα subunit is able to exchange its
GDP for GTP. As a result, both the α subunit as well as the βγ complex are activated and
able to interact with their targets in the membrane. After the subunits have transmitted
the signal and the ligand is no longer bound to the receptor, the components return to the
inactive state, shown in (a). The figures are taken from reference [26].
domain, allowing the Gα subunit to release the bound GDP and bind GTP instead.
The Gα-GTP complex decouples along with Gβγ to interact with a downstream ef-
fector protein, after which the GTP is hydrolyzed. The G protein then reforms back
to trimer, ready for a new activation process. The described process is demonstrated
in Fig. 2.4. GPCRs trigger the cAMP signaling pathway, in which the different G
proteins, Gs and Gi, cause opposite reactions. An activated Gsα subunit activates
an enzyme called adenylyl cyclase, which in turn converts adenosin triphosphate
(ATP) into cAMP. In contrast, the Gi protein reduces cAMP levels and inhibits
adenylyl cyclase. Increased cAMP will contribute to relaxation in smooth muscle,
together with increasing contractility and pulse rate in cardiac muscle [109]. The
correct operation of the cAMP pathways is crucial, since a deregulation of the cAMP
pathways and an aberrant activation of cAMP-controlled genes have been associated
to the growth of some cancers [110,111].
2.4. G Protein-Coupled Receptors – An Important Receptor Superfamily 13
Figure 2.5: The structure of the β2AR-Gs complex. The receptor is shown in green
with a ligand bound to the extracellular pocket, Gα subunit is bound to the receptor’s
intracellular domain and shown in gold, Gβ subunit is shown in cyan, and Gγ subunit in
violet. The figure is taken from reference [9].
2.4.1 Structure–Function Relationship of GPCRs
Several X-ray structures have been solved for rhodopsin-like GPCRs during the
past years, the first one being bovine rhodopsin, later accompanied by β1- and β2-
adrenergic receptors, dopamine D3 receptor, adenosine A2A receptor, histamine H1
receptor, muscarinic M2 and M3 receptor, etc. [112]. The importance of the work
within the structure discovery is highlighted by the Nobel Prize awarded in 2012 for
the discovery of the X-ray structure of β2-adrenergic receptor–Gs protein complex
(shown in Fig. 2.5) [9]. The discovered structures will enable further research on
more detailed properties of the receptor, such as function, activation, and regulation.
The residues in the cavity inside GPCRs at the extracellular side have been shown
to interact with ligands, triggering an outward tilting of the extracellular end of the
transmembrane helix 6 [113]. The movement causes conformational changes that
allow G protein coupling [114, 115]. These conformational changes occurring upon
activation are thought to be general across all rhodopsin-like GPCRs [116]. The two
states, activated and inactivated, are both assumed to exist in vivo as an equilibrium
controlled by some amino acids acting as micro-switches [117–120]. Agonists and
antagonists may stabilize either state by interacting with these residues. This mech-
anism is regulated by different amino acids depending on receptor, even though the
mechanism is general [121]. X-ray structures involving bound agonists have been
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found for β1- and β2-adrenergic receptors as well as for adenosine A2A receptor
during the recent years, and more are expected to come in the future [112]. The
structures will provide new insights for the research and for the rational drug design
of agonists and antagonists, elucidating the advantage of modeling even broader
structural changes [114,122]. Any knowledge available on the receptor function and
on the factors modulating it can be important in this process.
2.4.2 β2-Adrenergic Receptor Is a Characteristic GPCR
Adrenergic receptors (AR) are well-characterized GPCRs belonging to the rhodopsin
family, and responsible for example for triggering increased heart rate and mobiliza-
tion of energy in the so called fight-or-flight response [28]. They mediate signals from
the sympathetic nervous system to the cardiovascular system [123], responding to
ligands such as adrenaline in bronchial vasculature and noradrenaline in cardiac
muscle. The subtypes of adrenergic receptors, α and β, have different locations and
effects, and bind to different G proteins. Gs protein, which activates adenylyl cyclase
and causes smooth muscle relaxation, heart muscle contraction, and glycogen break
down, is bound by β1- ,β2- and β3-adrenergic receptors. Since β-adrenergic receptors
are highly important in cardiovascular and pulmonary physiology, they have many
agonists and antagonists with medical applications. β2AR agonists exist that are
asthma drugs, causing smooth muscle relaxation, rapid release of insulin, bronchial
passage dilation, and vasodilation, mimicking the effect of native ligands [24]. Some
βAR antagonists are used as beta blockers treating heart disease and hypertension,
slowing the heart rhythm and reducing blood pressure, hence diminishing the effects
of adrenaline [23]. This Thesis focuses on the properties of β2AR.
β2AR is expressed in pulmonary and myocyte tissue [12, 22]. It has been found
to couple to both Gs and Gi proteins in cardiac myocytes [124], but also to signal
without G protein, via arrestin [125, 126]. The structure of β2AR consists of seven
transmembrane helices typical for GPCRs, including a short eighth helix. Five of
the helices have a kink in the middle of the receptor, producing a structure pinched
in at the waist with cavities on both sides of the membrane. The structure of β2AR
in an inactive state has been determined with bound inverse agonists timolol [18]
and carazolol [16]. Also the active structure of β2AR has been discovered bound to
an agonist and to Gs protein [9], shown in Fig. 2.5. The activation of β2AR involves
a 7-14 Å outward movement of the intracellular end of the helix 6, and a 2 Å inward
movement of the extracellular end of the helix 5 [127, 128], shown in Fig. 2.6. The
Ras domain of the Gα subunit is in contact with the transmembrane helices 5 and
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Figure 2.6: The structure of β2AR in an inactive state (gray) compared to the active
state (green) of the β2AR-Gs complex. The figure is taken from reference [127].
6 of β2AR via its C-terminal helix, and this binding site exists only when β2AR is
in its active form. Cholesterol has been found to increase the kinetic, energetic, and
mechanical stability of β2AR [17], and is also required for its crystallization [16,18].
In addition to cholesterol, also phospholipids have recently been found to regulate
the activity of β2AR [129].
2.4.3 GPCRs Have Functional Consequences with Domains
It was proposed earlier that the GPCRs and G proteins are homogenously dis-
tributed along the membrane, diffusing freely and interacting in case they col-
lide [130,131]. However, this perspective has been questioned since the abundance of
GPCRs, G proteins, and their effector proteins is overall too low to provide sufficient
enrichment for rapid signaling processes that are characteristic for GPCR activa-
tion [132]. The concept of special membrane domains acting as compartmentalized
signaling complexes has provided a new perspective for GPCR signaling [13–15].
Several GPCRs have been found to localize in rafts or caveolae, either before or
after treatment with agonists [10]. For some GPCRs, agonists can promote entering
into rafts or caveolae, whereas for others, agonists have an influence promoting the
partitioning of the receptors out from these domains, which has been suggested to
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initiate receptor internalization or endocytosis and desensitization [54,58]. Adenylyl
cyclase, cyclic nucleotide phosphodiesterase, and protein kinase A, important sig-
naling components in the GPCR triggered cAMP pathway, can target to rafts or
caveolae [10]. Heterotrimeric G proteins have been found to interact directly with
caveolin proteins and to localize to caveolae [132, 133]. The interaction with cave-
olin has been found to help maintain the Gα subunits in an inactive state [134,135],
and caveolin scaffolding region is suggested to regulate the G protein function [135].
It has been later suggested that heterotrimeric G proteins dynamically partition
to lipid rafts surrounding GPCRs more preferentially than monomeric Gαq [12].
This signifies activity-dependent partitioning of G proteins that was suggested to
be driven by their lipid anchors [12]. Organization of the signaling components
can compartmentalize cAMP signals by creating cellular microdomains with either
higher or lower levels of cAMP [10]. The localization of the components to spe-
cific regions enables agonists to activate signaling pathways rapidly and with high
fidelity, especially when the signaling pathways require interaction of multiple com-
ponents [10].
As integral membrane proteins, a significant portion of GPCRs is embedded in
the membrane. For rhodopsin, the lipid–protein interface has been estimated to cor-
respond to ∼38% of the total receptor surface area [136]. Due to the large contact
area with the membrane, the lipid environment is thought to have an important ef-
fect on the receptor structure and function [76]. It has been proposed that targeting
GPCRs to lipid rafts and caveolae is one possible mechanism by which the mem-
brane alters the GPCR function [132,137,138]. One factor suggested to address the
GPCRs to ordered lipid rafts or caveolae domains is fatty acid modifications, such
as palmitoylation of cysteine residues in the C-terminal helix [139]. Palmitoylation
has been found to influence receptor activity, trafficking, and G protein coupling
for at least serotonin and oxytocin receptors [140]. Membrane cholesterol has been
shown to modulate the function of many GPCRs, although the mechanism is not
fully understood [141]. It has been suggested that cholesterol modulates the GPCR
function either directly inducing conformational change [142, 143], or indirectly by
altering the membrane physical properties [76, 144]. In addition to cholesterol, also
phospholipids have been found to regulate allosterically GPCR activity [129]. The
type of lipids directly interacting with GPCRs, such as cholesterol and certain phos-
pholipids, might also define the affinity for domains consisting of lipids compatible
with the lipids surrounding the GPCR [82].
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2.4.4 Current State in the Research of Membrane Domains
and GPCR Partitioning
The phase separation of lipids has been observed in model membranes of synthetic
lipids [3–5], where more pronounced differences in the properties of lipids yielded
more pronounced phase separation [3]. Certain proteins and lipids have been found
to be detergent insoluble [3], and proteins have been found to phase partition in gi-
ant plasma membrane vesicles [74] and in GUVs [19]. The phase separation of lipids
has also been shown computationally by MD simulation studies. In 2008 Risselada
and Marrink carried out simulations of a lipid bilayer comprised of saturated phos-
pholipids, polyunsaturated phospholipids, and cholesterol, obtaining spontaneous
separation of lipids into two phases [145]. One of the two phases was mainly com-
posed of saturated lipids and cholesterol, and the other contained only unsaturated
lipids and less cholesterol. The compositions of the two domains were found to
be consistent with a study based on NMR measurements having a similarly phase
separated model membrane [59]. Schäfer et al. observed in their joined study of
computational biology and confocal fluoresence microscopy of GUVs that model
transmembrane helices, such as WALP peptides, spontaneously partition into the
Ld phase [146], which was also found in another computational study by Doman-
ski et al., along with the result that the rhodopsin receptor as well prefers the Ld
phase [20]. A study by de Jong et al. interestingly showed that palmitoylation
of WALP peptides prodvided a driving force towards the more ordered membrane
domains, although the two saturated lipid anchors in the study were not sufficient
to allow the peptides to totally dissolve into the Lo domains [147].
It remains still ambiguous where the GPCRs reside in a membrane that is segre-
gated into two lipid phases, since several studies give contradictory results. For many
GPCRs the preference for domains has been proposed based on experimental find-
ings [10], for example βARs. Findings from some DRMs studies in 2001 suggested
rhodopsin to locate in the Lo domains [148], although it was shown by a GUV–based
study in 2005 [19] to prefer the Ld phase (Fig. 2.7). This result was repeated by
simulations in 2012, where rhodopsin was found to prefer the Ld phase irrespective
of hydrophobic mismatch, and it was suggested that the enthalpically unfavorable
disturbance of the tightly packed lipids in the Lo domains drives the protein into
the Ld domains [20]. Experimental study of rat ventricular cardiomyocytes from the
year 2000 shows localization of β1- and β2-adrenergic receptors to caveolar domains
where β2AR, but not β1AR, was found to translocate out of cardiomyocyte caveolae
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Figure 2.7: A dual-color confocal microscopy image of a bacteriorhodopsin–containing
giant unilamellar vesicle. AF633-CTXB (red) and AF488 (green) are fluorecent labels, of
which AF633-CTXB (right) reveals the region of the Lo phase, whereas AF488 (center)
shows the Ld phase. AF488 was distributed to membrane areas complementary to those in
which AF633-CTXB was localized, as shown in left where the two first figures are merged.
Bacteriorhodopsin is labeled with AF488, and thus shows preferential partitioning into the
Ld phase. The figures are taken from reference [19].
upon agonist stimulation [11]. On the other hand, since cholesterol is widely asso-
ciated with β2AR and needed for its stabilization [16–18], β2AR might be assumed
to prefer the Lo phase enriched with cholesterol. As it was postulated, the type of
lipids surrounding the protein might target the protein and the lipids surrounding
it to certain domains. However, there is no clear view where β2AR is located. The
objective of this study is to find out the β2AR preference for the Lo and the Ld
domains in a phase separated lipid bilayer by a MD simulation approach.
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3. MOLECULAR DYNAMICS
Biological processes occur over a wide range of spatial and time scales, for which
reason the method of the study should be chosen carefully. Whenever the processes
involve time scales too fast for human eye or length scales beyond microscopic limits,
computational simulations are an attractive alternative. They can provide details
that are not accessible through experiments, such as individual particle motions in
time, and provide access to unraveling more specific questions.
Molecular dynamics simulations have become a standard tool in the investiga-
tion of molecular level phenomena of biomolecules [149]. To date, it has yielded
success for example in the detailed investigation of processes occurring in cell mem-
brane level, such as receptor–ligand and receptor–lipid interactions related to drug
development [150]. MD simulations are based on classical physics, mimicking the
motions and distributions of atoms and molecules in real life. In terms of time
and length scales, simulations can now reach into the microscopic regime, forming
a bridge to experiments such as vesicle aspiration, fluorescence imaging, and atomic
force microscopy measurements [151]. Simulations are indeed often used to interpret
experiments, but also to discover new properties beyond current experimental tech-
niques [152]. The field of MD simulations is developing rapidly and becoming more
and more efficient, along with the development of computer hardware. There are
several software packages available for MD simulations of biological systems, such
as GROMACS, NAMD, and CHARMM. The simulations in this study were carried
out with the GROMACS software package [153].
The basics of the MD method is presented in the following sections. Force field
defines the interactions between the simulated particles, the time evolution is based
on the numerical evaluation of Newtonian equations, thermostat and barostat al-
gorithms regulate the system properties, and boundary conditions ensure that the
system does not have an unrealistic border with the vacuum. Next, the simulation
process, formed from the previous elements, is described, after which also the limi-
tations of MD are discussed. The studied system could be represented at different
levels of detail. Atomistic representation best reproduces the real-world systems, yet
coarse-grained representations are increasingly popular when large systems or long
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time scales are required [154]. In this study of β2AR partitioning in a phase segre-
gated membrane the Martini force field for coarse-grained molecules was used since
the phase separation and protein partitioning involve spatial and time scales that
are challenging for atomistic simulations. The coarse-grained model is presented
briefly in the end of this chapter.
3.1 Force Field Describes the Interactions
The particles simulated by MD obey the laws of classical mechanics in their motion,
that is caused by interactions with the other simulated particles. The interactions are
defined by the potential equations of the chosen force field. There are different kinds
of force fields in use for varying purposes; reactive force fields taking into account
chemical reactions [155], polarizable force fields focused on electronic polarizability
[156], all-atom force fields including specific representation of all involved atoms
[157], coarse-grained force fields using simplified models of functional groups [158],
etc. The choice of the force field must take into account the system properties as well
as the research question in order it to best suit the studied system and correspond
to the forces experienced between real particles. The force fields used in this thesis
were the coarse-grained Martini 2.2 force field and the all-atom OPLS (Optimized
Potentials for Liquid Simulations) force field. The particles in the force field are
considered as moving mass points, and the time evaluation of their movement is
obtained by numerically integrating the Newton’s equation of motion. Two types
of interactions can take place between the particles: bonded interactions between
defined groups of particles, and non-bonded interactions between particles, based
on their changing distance [159].
3.1.1 Bonded Interactions
Bonded interactions concern stretching, angle vibration, and dihedral angle torsion
of covalent bonds. The covalent bond stretching between two bonded atoms i and j,
illustrated in Fig. 3.1(a), can be described by a harmonic potential of the form [159]
Vbond(ri, rj) =
∑
bonds
1
2
kr(r − r0)2, (3.1)
where
r = |ri − rj| (3.2)
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Figure 3.1: Bonded interactions. The principle of (a) bond stretching, (b) bond angle
vibration, and (c) proper dihedral torsion.
is the distance between the atoms, kr is the harmonic force constant, and r0 is the
reference distance between the two atoms i and j.
The vibration of a covalent bond angle formed between three atoms i, j, and k,
shown in Fig. 3.1(b), is described by a harmonic angular potential given by [159]
Vangle(ri, rj, rk) =
∑
angles
1
2
kθ(θ − θ0)2, (3.3)
where
θ = arccos
rij · rkj
rijrjk
(3.4)
is the angle between the bonds, and θ0 is the reference angle.
The dihedral angle φ is defined by the positions of atoms i, j, k, and l as the angle
between the normals to the two planes (i, j, k) and (j, k, l) (Fig. 3.1(c)) [159]. An
angle of zero corresponds to the cis and an angle of 180o corresponds to the trans
configuration. The proper dihedral potential is described by a periodic function
given by [159]
Vdihedral(φ) = kφ(1 + cos (nφ− φ0)), (3.5)
where kφ is the force constant, n the periodicity, and φ0 the reference angle. Instead
of using an interaction between atoms i and l, a set of periodic functions with
different periodicity can be used, or a set of powers of cosine functions as in the
Ryckaert-Belleman’s (RB) potential given by [153]
VRB =
5∑
n=0
Cncos
nφ, (3.6)
where Cn(n = 0, ..., 5) are the Ryckaert-Belleman torsion parameters. GROMACS
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uses the Ryckaert-Bellemans equation to compute Fourier dihedrals of the form [153]
VF(φijkl) =
1
2
[C1(1 + cos(φ)) + C2(1− cos(2φ))
+ C3(1 + cos(3φ)) + C4(1 + cos(4φ))]. (3.7)
Additionally, improper dihedrals are defined in order to prevent molecules from flip-
ping over to their mirror images or to keep planar groups planar, such as aromatic
rings. The improper dihedrals are based on four atoms i, j, k, l as the proper dihe-
drals, and given a harmonic restraining potential [159]
Vimproper =
1
2
kξ(ξ − ξ0)2, (3.8)
where kξ is the force constant, ξ the improper dihedral angle between the planes
(i, j, k) and (j, k, l), and ξ0 is the corresponding referencem angle.
3.1.2 Non-bonded Interactions
Non-bonded interactions act between particles that are not linked to each other by
a covalent bond. They are defined as a function of the distance rij between the two
particles. The non-bonded interactions are usually considered with a certain cut-off
radius in the simulated system, meaning that after excluding pairs that are already
involved in the bonded interactions, the non-bonded interactions are only calculated
for pairs whose distance rij is less than the cut-off radius. The particles involved in
the non-bonded interactions will thus fluctuate during the simulation and must be
updated regularly. The pairs for which the non-bonded interactions are calculated,
are added to a neighbour list [153]. The non-bonded interactions are formed from
the sum of van der Waals interactions and Coulomb interactions, of which the van
der Waals potential has the form of the Lennard-Jones (LJ) potential given by [157]
VLJ(rij) = 4ij
((σij
rij
)12
−
(σij
rij
)6)
, (3.9)
where σij and ij are constants giving the reference distance and minimum energy
of the potential well. The first term of the equation describes a strong short-range
repulsion, taking place if the particles are overlapping. The second term describes
a longer-range dispersion between the two particles.
Coulomb interactions take place between charges or partial charges of atoms and
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is given by [157]
VC(r) =
∑
i<j
qiqje
2
ijrij
fij, (3.10)
where e is the elementary charge and qi, qj are the charges of particles i, j, respec-
tively. The total potential acting on a particle can be calculated as a sum of all the
potentials [153]:
Vtot =
∑
Vbonded +
∑
Vnon−bonded. (3.11)
The Coulomb potentials do not decrease rapidly with distance like the van der
Waals interactions, implying that the electrostatic interactions beyond the cut-off
radius can not be completely neglected. Methods such as the Ewald summation are
commonly used for efficient computational evaluation of these interactions [160].
In addition to the potentials presented above, specially defined potentials can
be used for restricting the motion of the system in order to for example avoid
rearrangement of certain parts during the equilibration of the system or to include
some knowledge obtained from experimental studies. These position restraints are
used to keep particles in a fixed reference position by imposing forces on the given
particles [153].
3.2 Time Evolution Stems from Solving the Equations of Mo-
tion
The time evolution of the system in MD simulation is obtained by numerically
solving the Newton’s equation of motion. For a system of N interacting atoms the
Newton’s equation of motion are given by
mi
∂2ri
∂t2
= Fi, i = 1...N, (3.12)
where mi is the mass of the particle i, ri is the position of the particle at time t, and
Fi is the force acting on the particle. The forces can be obtained from the negative
derivative of the potential function V (r1, r2, ..., rN):
Fi = −∂V
∂ri
. (3.13)
The equations ( 3.12) and ( 3.13) are computed using a time integration algorithm.
GROMACS uses the so-called leap-frog algorithm [161] as default for the integration
of the equation of motion [153]. It updates the positions and the velocities in different
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points of time using the forces F(t) determined by the positions of the particle at
time t. The equation for the velocity in the leap-frog algorithm is given by
v(t+
1
2
∆t) = v(t− 1
2
∆t) +
∆t
m
F(t), (3.14)
and the equation for the position is given by
r(t+ ∆t) = r(t) + ∆t(t+
1
2
∆t), (3.15)
where v is the velocity at time t− 1
2
∆t and r is the position at time t [153].
3.3 Temperature and Pressure Coupling Maintain the Correct
Ensemble
It is almost always necessary to implement some modifications to the Newtonian
equations in order to avoid undesirable effects resulting from inexact solutions of
the equations. Usually it is desirable to simulate the system in constant tempera-
ture and pressure, in a so-called isobaric-isothermal NpT ensemble, as experiments
are often carried out in similar constant conditions. GROMACS has algorithms
called thermostats and barostats designed for the temperature and pressure cou-
pling, respectively; with these algorithms the temperature and the pressure of the
system can be controlled during the simulation [153].
For simulation in constant temperature, GROMACS can use several thermostats
such as Berendsen, velocity rescale, Andersen, and Nosé-Hoover [153]. The weak-
coupling scheme of Berendsen uses an external heat path with temperature T0.
The algorithm slowly corrects the deviation of the system temperature T to the
temperature of the heat bath T0 by following the equation
dT
dt
=
T0 − T
τ
, (3.16)
where τ is the time constant for exponential decay [153]. The Berendsen method is
efficient in the equilibration phase of the system, but it does not produce a correct
ensemble since it suppresses the fluctuations of the kinetic energy and pressure.
The velocity rescaling method is an improved version of Berendsen thermostat that
creates a correct kinetic energy distribution due to an additional stochastic term,
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resulting inthe form:
dK = (K −K0) dt
τT
+ 2
√
KK0
Nf
dW√
τT
, (3.17)
whereK is the kinetic energy andK0 the kinetic energy at equilibrium, dW a Wiener
process, Nf is the number of degrees of freedom, and τT is close to the time constant
τ defined by
τT =
Ndfkτ
2CV
, (3.18)
where Ndf is the total number of the degrees of freedom, k is the Boltzmann’s
constant, and CV is the total heat capacity of the system [153].
The system pressure coupling can be done in GROMACS for example by Berend-
sen, Parrinello-Rahman, velocity Verlet, or MTTK (Martyna-Tuckerman-Tobias-
Klein) methods [153]. The Parrinello-Rahman algorithm changes the periodic box
size in order to force the current pressure P towards the desired reference pressure
Pref . Both P and Pref are represented as tensors, each element of which is the
force that acts on the surface of an infinitesimal cubic volume. In isotropic situa-
tions, where forces are same in all directions and in the absence of viscous force, the
pressure tensor is diagonal and usually referred to as a scalar quantity. In material
science studies, however, the pressure is referred to as a stress tensor, the diagonal
elements of which are known as the tensile stress and the non-diagonal elements as
the shear stress. The box vectors are represented by a matrix b, and they are forced
to obey the matrix equation of motion given by
db2
dt2
= VW−1b′−1(P−Pref ), (3.19)
where t is time and W is a mass parameter matrix determining the strength of the
coupling and how the box can be deformed. The mass parameter matrix is given by
(W−1)ij =
4pi2βij
3τ 2pL
, (3.20)
where βij are the isothermal compressibilities, L is the largest box matrix element,
and τp is the pressure time constant of the algorithm [153]. The Parrinello-Rahman
algorithm is commonly used in pressure-coupling but may result in very large box
oscillations if the system pressure is far from equilibrium. The Berendsen algorithm
converges quickly and is therefore more suitable for the equilibration of the system,
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Figure 3.2: A schematic illustration of periodic boundary conditions.
after which the barostat is often switched to a more sophisticated one, such as the
Parrinello-Rahman barostat [153].
3.4 Periodic Boundary Conditions Reduce Boundary Artifacts
An important property to be considered as well, is the overall shape of the system.
Long-range interactions, especially those of electrostatic origin, highly depend on
the boundary conditions applied to the system. The simulated system has some
restrictions in size since it can not be infinite. Therefore the system boundaries
should be carefully defined in order to avoid artifacts. A very simple way to overcome
this problem is to apply periodic boundary conditions (PBCs) to the system.
The PBCs exactly replicate the system in three dimensions and provide a periodic
lattice consisting of unit cells. When a particle moves out of the periodic simulation
box, it instantly enters the box from the opposite side as illustrated in Fig. 3.2.
Thus there are no boundaries of the system, only a space-filling box surrounded by
translated copies of itself, thus the edge effect are minimized [159]. On the other
hand, in a too small system the particles might interact with other particles more
than once, which will cause undesired edge-effects. Therefore the size of the box must
be chosen with care. The minimum image convention ensures that a given particle
only interacts with the closest copy of another particle. Only the interaction with
either a particle in questionper or its periodic image is taken into consideration,
which one ever is closer.
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3.5 Proceeding to the Simulation
A simulation study begins with the system preparation. For this purpose the initial
conformations of the molecules are needed, provided for example by an X-ray struc-
ture or a theoretical model. Once all the needed structures are available, the system
can be built by defining the positions for all atoms in each molecule. In addition
to coordinates defining the positions, the structure of a system is defined by atomic
velocities and by the forces acting on each atom. Atomic properties, such as their
masses, charges, and bonded interactions must be defined in the topology of the
system [153]. The size and the shape of the periodic box are also required before
starting the simulation.
If the generated starting configuration of the system is far from equilibrium, some
interactions might be high in energy and the MD simulation may fail due to this
instability [153]. Therefore energy minimization is needed before starting the real
simulation. The potential energy function of the system is very complex and has
a global minimum as well as several local minima. The energy minimization finds
the nearest local minimum of the potential function. The steepest descents method,
that is possible to use in GROMACS, will bring the system potential function close
to the nearest local minimum quite quickly by an algorithm that takes a derivative
of the potential function in the direction of the negative gradient until it finds the
local minimum [153]. In addition to the energy minimization, the system often needs
some time for equilibration for example to stabilize the structure of a molecule, and
therefore a comparatively short equilibration phase might be needed. After having
the system energy minimized and equilibrated, one can proceed to the production
phase of the simulation.
In general, MD simulations are based on an algorithm simplified in Fig. 3.3.
The initial conditions, such as the positions and velocities, are first given to each
particle. Next, the forces acting on the particles are calculated from the potential
equation. After the forces, velocities and positions are known, the following step is
to calculate new positions. The velocities are then calculated in these new positions
with the leap-frog algorithm and scaled with thermostat and barostat to force the
system into the correct ensemble. The time will be increased at this point, and
if required, some information about the system such as the positions, velocities,
potentials, temperature, etc. can be written down in the output file. This cycle is
then repeated as many times as required until the desired amount of time steps has
been reached. After finishing the simulation, the output files are used to analyze
the results.
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Figure 3.3: The simplified MD algorithm.
3.6 Limitations of Molecular Dynamics Simulations
The MD simulation method is a good approximation of real life events, yet it should
be highlighted that it is based on a variety of approximations and assumptions that
cause limitations for its use. Since the MD method is based on classical physics,
the simulations work for most of the atoms at normal temperatures, but some pro-
cesses, such as the proton or electron tunneling or chemical bonding, can not be
properly treated by classical dynamics. MD simulations are restricted by the Born-
Oppenheimer approximation which does not take the motions of electrons into con-
sideration [153]. Electrons are supposed to adjust their atomic positions instantly
upon a change in position, and remain in their ground state, for which reason the
electron transfer processes and electronically excited states can not be treated [153].
Major limits for MD simulations are set by the simulation time scale and the
system size due to computational power available. In the beginning of the 2010s,
reasonable limit was a million particles corresponding to roughly about 5000 all-
atom lipids, and simulation times of microseconds [151]. On the other hand, by
going down in resolution from all-atom models to simplified coarse-grained models,
the respective reachable limits were about 50 000 coarse-grained lipids, and time
scales up to millisecond scale [151]. During the past few years, advances in software,
hardware, and simulation techniques have even made milliseconds of atomistic sim-
ulations possible [162], and the accessible limits continue increasing.
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Figure 3.4: Representation of a lipid from all-atom to coarse-grained model.
3.7 Martini Coarse-Grained Force Field Provides a Simplifi-
cation
The time scales of a variety of biologically interesting phenomena, such as dynam-
ics of large proteins and the lipid phase separation, are currently challenging to
reach with atomistic simulations. The Martini method developed for coarse-grained
molecular modeling provides an alternative by allowing simulation times on length
and time scales 2-3 orders of magnitude larger compared to atomistic simulations
with the same computational effort [158]. This is done by simplifying the atomistic
molecular models (Fig. 3.4). While in atomically detailed models the particles cor-
respond to individual atoms in the system, in coarse-grained models several atoms
are grouped into beads which reduces the number of force centers and thus the com-
putational effort of the force evaluation [163]. The reduction of the number of force
centers however leads to less friction between simulated molecules and thus speeds up
their diffusion compared to atomistic systems [163]. Generally, the time in Martini
simulations equals to around 4 times longer time in atomistic simulations [163,164].
The Martini force field parameters have been developed for several biomolecules,
including lipids, proteins, and DNA [158, 163, 165]. The force field parameters are
not based on accurate knowledge of atomistic details, but instead the parameters
can be used in a more general manner in a variety of different applications without
the need to reparameterize by using the beads as building blocks.
The proteins in the Martini force field can be simulated in combination with an
elastic network in order to help preserve their higher-order structure. An elastic
network can be used as a structural scaffold to describe and maintain the overall
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shape of a protein by adding extra harmonic bonds to the standard Martini topology
between non-bonded beads based on a distance cut-off. The resulting structural and
dynamical properties of a protein in MD simulations with an applied elastic network
are comparable to those obtained using atomistic protein models [166]. Notable is
that conformational changes necessary for protein folding can not be expected to
produce because of the elastic network’s built-in structural bias toward the reference
configuration [166].
Since the chemical resolution of a coarse-grained system is limited, some prop-
erties of varying importance are lost. For some phenomena, small changes such as
tilting of an individual lipid, are not important in the overall picture, such as phase
separation of lipids, yet this might be critical in, for example, protein-lipid inter-
actions. Therefore the conversion of a coarse-grained system on atomistic model is
sometimes necessary to obtain insight about atomistic–scale processes from coarse-
grained simulations. The conversion from a coarse–grained to an atomistic model
and vice versa is possible with several scripts available [165,167,168].
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4. SIMULATION MODELS AND ANALYSIS
METHODS
The aim of this study was to find out the preference of β2AR for domains in a phase
segregated bilayer. From the computational perspective, it is extremely important,
first of all, to choose correct models for the molecules in order to correctly mimic the
underlying biology. Next, the system settings from the point of view of the study
must be chosen, while aiming to get results reliable enough and balancing with the
computational power available. Finally, the obtained simulations must be analyzed
with care, and the most informative ways to present the significant results from
the massive amount of data must be discovered. In this chapter the preparation
procedure of the studied systems is presented, along with the simulation parameters
and details, and the analysis methods used.
4.1 Systems
The lipid bilayer simulated by Risselada and Marrink [145] was used as a platform for
the simulations. The lipids dipalmitoyl-phosphatidylcholine (diC(16:0)PC, DPPC),
dilinoleoyl-phosphatidylcholine (diC(18:2)PC, DLiPC), and cholesterol (CHOL) were
used with the DPPC:DLiPC:CHOL ratio being 42:28:30, and the total number of
lipids of 2200. This lipid mixture was found to spontaneously form a strongly
phase separated bilayer composed of a disordered Ld domain and an ordered Lo do-
main [20]. The CHARMM-GUI graphical user interface [169] was used for building a
patch of the lipid bilayer with the bilayer builder in the Martini maker options [170].
The bilayer contained 231 DPPC, 154 DLiPC, and 165 CHOL molecules, consisting
of 550 lipids in total. 50 Å of water was added on both sides of the bilayer, totaling
∼44000 coarse–grained water beads, along with 1040 Na and Cl ion molecules to
reach the physiological salt concentration of 0.15 M. The system was equilibrated
and multiplied by 4 in order to obtain the bilayer of 2200 lipids. The protein was
then embedded in ten different locations yielding ten systems, R1-R10, with differ-
ent starting structures. The GROMACS tool gmx solvate was used to insert the
protein in the bilayer and to remove the overlapping lipid, water, and ion molecules.
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After embedding the protein, the total number of lipids was adjusted to 2000, the
same as in Risselada’s and Marrink’s study [145], and the number of ions was modi-
fied in order to balance the charges in the system that now contained protein. The
locations of the protein in each system are shown in Fig. 4.1(a). Another two sys-
tems, RC1 and RC2, were constructed by embedding the protein in the bilayer in
the same locations as in systems R1 and R9, respectively. In these systems the
CHOL parameter developed by M. Daily et al., discussed in more detail in the next
section, was used [171].
The lipid bilayer was simulated for 5 µs until the phase separation of lipids had
occurred. This system was then used as a platform to embed the protein with a
similar procedure in ten different locations, yielding five systems, O1-O5, with the
protein initially in the Lo phase, and five systems, D1-D5, with the protein initially
in the Ld phase. The locations of the protein embedded to the phase separated
bilayer are shown in the Fig. 4.1(b), and a side view of the system in Fig. 4.2.
The atomistic systems were constructed with backmapping script provided in
reference [167]. Approximately 1/4 of the lipids around the protein in the systems
R1 and D1 were backmapped from coarse–grained to atomistic systems B1 and
B2, respectively. The simulation of an atomistic system is computationally more
costly, and therefore only 1/4 of the coarse–grained systems was backmapped to
atomistic detail. The system R1 was backmapped after the 6 µs of simulation,
yielding the system B1 with the lipid composition listed in Table 4.1. In this system
the protein was in the boundary of the Lo and Ld phases. The initial structure of the
system D1 after equilibration, where the protein was entirely in the Ld phase, was
backmapped yielding the system B2 with lipid composition listed in Table 4.1 as well.
These configurations were chosen for backmapping in order to enable the protein to
spontaneously create its preferred environment in the atomistic simulations. The
original lipid ratio was not the same as in Martini systems since the protein location
dictated the lipids to be backmapped. The DLiPC molecules were backmapped into
dioleoyl-phosphatidylcholine (diC(18:1)PC, DOPC) due to the force field parameters
available. DOPC is an unsaturated lipid like DLiPC, but has only one double bond
in each chain instead of two.
The backmapped systems were equilibrated first with position restraints on all
protein atoms, and on lipid head groups and chains in the z-direction (direction
perpendicular to the bilayer plane) until the bilayer filled the simulation box in
the x- and y-dimensions. In both systems only the lipids were backmapped, and
water and ions were added after the equilibration of the box. The systems were
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(a) Protein embedded in S1 (b) Protein embedded in S2
Figure 4.1: A top view of the simulation box of (a) the bilayer with random lipid distri-
bution, in which the protein was embedded to generate different starting structures for ten
individual systems R1-R10, and (b) the phase separated bilayer, in which the protein was
embedded to generate five different starting structures with the protein in the Lo phase
(O1-O5) and five with the protein in the Ld phase (D1-D5). The DPPCs are shown in
cyan, forming the Lo phase together with CHOL that is shown in yellow, and the Ld phase
is mainly composed of DLiPCs shown in red. The circles indicate the locations in which
the protein was embedded in the system in question.
Figure 4.2: A side-view of the simulation box of the phase-separated bilayer. Water is
shown in blue, facing the bilayer from upper and lower sides. CHOL molecules are shown
in yellow, DPPC in cyan, DLiPC in red, and the phosphorus containing groups are shown
in ochre.
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Table 4.1: The system compositions. The protein was placed in the lipid bilayer contain-
ing 2200 lipids, which yielded systems R1-R10, O1-O5, and D1-D5 that differ in protein
location. In systems RC1 and RC2 the protein was embedded at the same locations as in
R1 and R9 respectively, but was simulated with a different CHOL parameter. Systems B1
and B2 are smaller, atomistic systems, backmapped from systems R1 and D1, respectively.
R1-R10,O1-O5,
Molecule Number D1-D5, RC1,RC2 B1 B2
(coarse-grained model) (all-atom model)
β2AR - 1 1 1
DPPC 924 840 193 183
DLiPC 616 560 - -
DOPC - - 153 169
CHOL 660 600 148 143
Lipids in total 2200 2000 494 495
Table 4.2: The protein initial location in the constructed systems, CHOL parameters
used, and the simulation times of the systems.
Protein CHOL Run time
Forcefield System location parameter (µs)
Lipid bilayer - [172] 5
R1-R10 Random [172] 10
Martini O1-O5 Lo phase [172] 10
D1-D5 Ld phase [172] 10
RC1, RC2 Random [171] 10
B1 Lo/Ld border [173–175] 2
OPLS-AA B2 Ld phase [173–175] 2
then equilibrated without any restraints on the lipids, but keeping the ones on the
protein atoms until the bilayer had stabilized. The protein restraints were then
released in steps by first equilibrating the system for 10 ns with position restraints
on the protein heavy atoms, and then for 20 ns with position restraints on the
protein backbone. After the equilibration, the systems were run for 2 µs, as listed
in Table 4.2.
4.2 Molecular Models of the Structures
The initial structure of the human β2AR (residues 32-342) in the OPLS-AA force
field used in the simulations was obtained from the PDB id 3D4S [18], with modi-
fications discussed in [174]. The fine grained structure of the protein in OPLS-AA
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Figure 4.3: The structure of β2AR used in this study [174]. The transmembrane helices
are colored for clarity: helix 1 (blue), helix 2 (cyan), helix 3 (green), helix 4 (yellow), helix
5 (orange), helix 6 (red), helix 7 (purple), and a short helix 8 (magenta). Intracellular
loops are shown in grey and extracellular loops in pink.
force field was converted into a coarse-grained one, to the Martini 2.2 force field, by
using the script martinize.py provided by the Martini development team [165,168].
An elastic network was used for the coarse-grained protein with an elastic bond force
constant of 500 kJ·mol−1·nm−2, with lower and upper elastic bond cut-offs of 0.5
and 0.9 nm, and with bond strengths independent of the bond length. The structure
of β2AR is shown in Fig. 4.3.
The size of the Martini coarse-grained cholesterol size has been found to have a
significant impact on the behavior of cholesterol-containing bilayers [176]. A choles-
terol parameter with a virtual site description developed by M. Melo, H. Ingólfsson,
and S. Marrink [172] was used in systems R1-R10, O1-O5, and D1-D5 instead of the
earlier Martini cholesterol model [158] that has been reported to drive the Lo phase
too ordered and fail to preserve its fluidity [177, 178]. The cholesterol parameter of
Melo & al. was developed by reparameterizing the earlier Martini cholesterol model,
by adjusting its packing properties to a allow a proper Lo cholesterol behavior, and
stabilizing it by reformulating the spatially constrained cholesterol topology using
virtual interaction sites [172]. Another cholesterol parameter for Martini developed
by M. Daily et al. was reported to better mimic the properties of atomistic choles-
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(a) Coarse–grained lipids (b) Atomistic lipids
Figure 4.4: (a) The coarse-grained models of the lipids, and (b) the atomistic models of
the lipids. The beads of coarse-grained PC lipids are colored separately: nitrogen group
(N) in blue, phosphate group (PO4) in pickle green, glycerol groups (GL) in pink, and
chain carbon groups in purple if containing double bonds (D), otherwise in cyan (C). The
beads for cholesterol ring structure are shown in purple and the hydrocarbon chain beads
in cyan. The atoms of the fine–grained lipids have similar color codes: nitrogen is shown
in blue, phosphorus atoms in pickle green, oxygen in red, carbon in cyan, and hydrogen in
white.
terol [171], and was used in systems RC1 and RC2. The Martini coarse-grained
force field parameters were used in all Martini systems for saturated DPPC lipids
and for the unsaturated DLiPC lipids, as well as for water and ions [158, 163, 179].
Fig. 4.4 shows the coarse–grained representations of the DPPC, DLiPC, and CHOL
molecules. The lipid parameters in the all-atom OPLS force field were taken from
references [180–182] for DPPC and DOPC, from references [173–175] for CHOL, and
from [174] for β2AR. The TIP3P water model, compatible with the OPLS parame-
terization, was used for water [183].
4.3 Simulation Details
All simulations were carried out with the GROMACS 5.0.x MD package [184]. The
coarse-grained systems (R1-R10, RC1-RC2, O1-O5, D1-D5) were simulated with the
Martini 2.2 force field [163,165] with a 20 fs integration step. In all simulations the
solvent molecules, lipids, and the protein were independently coupled to a constant
temperature bath [185] with a time constant of τT = 1.5 ps at a temperature of
295 K that was also used in Risselada’s and Marrink’s simulations [145]. At this
temperature the liquid domains were observable and stable. The pressure was weakly
4.3. Simulation Details 37
coupled [185] to 1 bar with a time constant of 3.0 ps. The semi-isotropic coupling of
the pressure was applied in the xy-plane (the membrane plane), and independently
in the z-direction. The Coulomb interactions were treated with a Coulomb potential
that is screened with a relative dielectric constant of r = 15. The Lennard-Jones
potential was smoothly shifted to zero between 0.9 nm and 1.1 nm and the Coulomb
potential between 0 nm and 1.1 nm.
The lipid bilayer with a random lipid distribution obtained with CHARMM-GUI
was energy minimized for 5000 steps and then equilibrated for 10 ns with a time
step of 20 fs. After the protein was embedded in each coarse-grained system, the
systems were energy minimized for 5000 steps and then equilibrated for 4 ns, first
with position restraints on all protein beads, lipid head groups and chains, and on
water and ion molecules in z-direction, and finally equilibrated without any restraints
for 10 ns. The systems were then run for 10 µs each. The simulation times are listed
in Table 4.2. The simulation time of the coarse-grained systems should be scaled
by using a standard conversion factor of 4 [163]. The total effective time sampled is
therefore ∼40 µs for each coarse-grained system.
The OPLS-AA force field [157] was used in the systems B1 and B2 with a 2 fs time
step. The simulations were performed at 295 K as well by employing the v-rescale
thermostat [186] with a time constant of 0.1 ps. The pressure was coupled to 1 bar
with the Parrinello-Rahman barostat [187] and with a time constant of 1 ps. The
Lennard-Jones interactions were cut off at 1.1 nm. For the long-range electrostatic
interactions, the particle mesh Ewald method (PME) [188] was employed with a
real space cut-off of 1.0 nm, β-spline interpolation (order of 6), and a direct sum
tolerance of 10−6.
The simulations were performed in the isobaric-isothermal (NpT) ensemble. In
each of the systems, PBCs were applied in three dimensions. All the systems were
energy minimized using the steepest descent algorithm. The LINCS algorithm was
used to constrain the bonds between the atoms [189]. The neighbor search algorithm,
the grid, updated neighbor lists every 10 time steps. Visual images of the systems
or their compounds were prepared using the VMD (Visual Molecular Dynamics)
software [190] version 1.9.1. The simulations were performed in the Center for
Scientific Computing (CSC) in Finland and in the Tampere Center for Scientific
Computing (TCSC).
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4.4 Analysis Methods
Many tools are available for the simulation data analysis, for instance some built-
in tools provided by the GROMACS software package [153] or other tools freely
available. However, some tools must be developed further or from scratch in order
to present the data in a specific form. The most informative analysis tools used in
this study are presented below. All analyses were performed with a time resolution
of 200 ps and for the last 5 µs trajectory of each coarse-grained system unless
mentioned otherwise. For atomistic systems, a time resolution of 100 ps was used
and the last 1 µs trajectories were chosen for the analyses.
4.4.1 Fraction of Lipid–Lipid and Protein–Lipid Contacts
A contact is considered to take place between two atoms or molecules if the dis-
tance between them is less than a certain cut-off distance. The fraction of lipid–
lipid contacts was calculated by dividing the number of contacts between the sat-
urated (DPPC) and unsaturated (DLiPC or DOPC) lipids by the total number
of contacts between unsaturated and all PC lipids (DPPC and DLiPC/DOPC).
The fraction of the β2AR–lipid contacts was calculated by dividing the number of
β2AR–unsaturated lipid contacts by the number of β2AR–all PC lipid contacts. The
number of contacts was calculated with GROMACS tool gmx mindist [153], and
the cut-off distance used was 0.6 nm.
4.4.2 Concentration of Lipids
The local concentration of any lipid type in the membrane was calculated by first
taking the last 1 µs trajectory of each system and then calculating the center of
mass (COM) coordinates of each lipid with the GROMACS tool gmx traj [153].
The membrane was then divided into 20 slabs, of approximately 1.1 nm of width,
along the axis perpendicular to the phase boundaries. The number of each lipid
type in each slab was then calculated based on the COM coordinates of the lipids.
The number of the lipids in question was divided by the total number of lipids in
each slab in order to obtain the fraction of the lipids in that slab.
The concentration of lipids in the membrane at certain distances from the protein
was calculated similarly. The lipids where divided into 20 groups based on the
distance between the COM of each lipid and protein. The distances defining the
groups were [0., 1.5), [1.5, 2.0), [2.0, 2.5), [2.5, 3.0),...,[9.5, 10.0). The fraction of each
lipid type in a certain group was then calculated by dividing the number of lipids
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in question by the number of lipids in the group.
4.4.3 Radial Distribution Function
The radial distribution function (RDF) is used to determine the distribution of
particles around a reference particle. RDF or in other words the radial distribution
gAB(r) between particles of type A and B is defined by [153]
gAB(r) =
〈ρB(r)〉
〈ρB〉local
=
1
〈ρB〉local
1
NA
NA∑
i∈A
NB∑
i∈B
δ(rij − r)
4pir2
(4.1)
where NA and NB are the number of particles of type A and B, respectively, 〈ρB(r)〉
is the particle density of type B at a distance r around the particle A, and 〈ρB〉local
the particle density of type B averaged over all spheres around the particle A. The
calculation of RDF is based on an algorithm that determines the number of particles
within a distance between r and r + dr from a reference particle for every r. The
results can be plotted giving the density of certain particles as a function of the
distance. The RDF can be regarded as a measure of the probability of finding a
particle at a distance r from the reference particle.
In this study the analysis tool gmx rdf provided by GROMACS [153] was used
to calculate the radial distribution function of the COM of the lipid molecules from
the protein in x- and y-dimensions. PBCs were used to calculate the distances, and
the trajectories were divided into 2 µs intervals for which the RDF was calculated
in order to find out the time evolution.
4.4.4 Two-Dimensional Number Density
A two-dimensional (2D) number density map shows the spatial distribution of lipids
in the bilayer plane. For this analysis, the protein molecules were first centered in the
simulation trajectory, and the rotational and translational motion of the protein were
removed from the analysis. With the GROMACS tool gmx traj [153] the center of
mass coordinates of each lipid were calculated separately, as well as the coordinates
of the upper and lower parts of the protein TM helices. The trajectories of the
systems with a similar starting configuration were merged into longer trajectories,
the systems with an initially random lipid distribution (R1-R10) were concatenated,
and this was also done for systems with the protein initially in the Lo phase (O1-O5),
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for the systems with the protein initially in the Ld phase (D1-D5), and for systems
RC1-RC2.
The box dimensions were calculated for each trajectory with the GROMACS tool
gmx energy, and the greatest box dimension was used to divide the box into a grid
in such a way that one spatial step in the grid corresponds to approximately 1 Å.
The average of the COM coordinates of the lipids in the z-direction were used to
define the center of the bilayer at each time step. The lipids of each type (DPPC,
DLiPC/DOPC, CHOL) were then divided into the upper and lower leaflet based
on their z-coordinate value, yielding six density maps for each trajectory. The
contribution of each lipid was added to the corresponding grid point in the density
map. The coordinates of the COM of each lipid were also checked to be inside the
box in order to get the contribution of each lipid to fit in the density map. Finally,
the maps were normalized by dividing the number of frames in the trajectory and
by the number of lipids in question. Similar density maps were also calculated for
the upper and lower parts of the protein TM helices, and the location of the protein
helices was added to the obtained lipid number density maps.
4.4.5 Lipid Occupancy Time per Residue
The number of contacts between each lipid type (DPPC, DLiPC/DOPC, CHOL)
and each protein residue were averaged over the systems R1-R10, RC1-RC2, O1-
O5, and D1-D5. The residues were considered to be in contact with a lipid if the
distance between them was equal to or less than 0.6 nm. The -group option of the
GROMACS tool gmx mindist was used to count the contacts of multiple lipids of
the same type with a protein residue as one contact at one time step. The total
occupancy time was normalized in such a way that the occupancy time of 1 indicated
a contact that lasted throughout the simulation, whereas the value of 0 means lack
of contacts. The total occupancy time per protein residue was plotted on the protein
surface separately for each lipid type with VMD.
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4.4.6 Lipid Tail Order Parameter and Bilayer Thickness
The order of the lipid bilayers is characterized by an order parameter that can be
measured by deuterium NMR. The order parameter describes the average orientation
of the carbon chains and describes how straight or twisted they are. For lipid chains
in atomistic systems the order parameter is described by the equation [153]
Sz =
3
2
〈cos2θz〉 − 1
2
, (4.2)
where θz is the angle between the z-axis of the simulation box and the vector
between two sequential carbon atoms in the lipid chain. The squared cosine values
of the angles are averaged over time and molecules in order to obtain the order
parameter Sz that has a value between −0.5 and 1, where the value of 1 implies full
order perpendicular to the normal. The order parameters calculated for the Martini
coarse-grained lipids with this method do not compare to any values obtained in
atomic systems, since multiple chain carbons are considered as one bead, and the
order parameter values are obtained between the beads that are segments in the
chain. However, the order parameter values between different Martini coarse-grained
lipids are comparable, so it gives some hint of the differences in the order between
for example regions in one system or two completely different systems.
In this study the order parameters of the Martini coarse-grained lipid chains
were calculated using Eq.(4.4.6), with the script do-order-multi.py provided by
the Martini development team [163]. The chain beads GL1-C4A and GL2-C4B of
the Martini coarse-grained PC lipids were chosen for the analysis. The local lipid
chain order parameter and bilayer thickness were calculated in the xy-plane using
the tool g_lomepro [191], which analyzes the local properties of the membrane (lipid
tail order parameters, membrane thickness, area per lipid, membrane curvature) in
two or three dimensions based on a grid. The bilayer thickness was calculated as
the average distance in the z-direction between the phosphorus containing groups
of the PC lipids in the upper and lower leaflets. The systems with a similar starting
structure were concatenated into same trajectory for the calculation.
4.4.7 Diffusion Coefficient
The diffusion coefficient DA of the molecules of type A in the bilayer can be deter-
mined by first calculating the mean squared displacement (MSD) 〈||ri(t)− ri(0)||2〉
of all molecules i in the group A. To determine the coefficient DA, one can use the
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Einstein relation [153]
lim
t→∞
〈||ri(t)− ri(0)||2〉i∈A = 4DAt, (4.3)
which says that in a two-dimensional system, a four-fold diffusion coefficient DA is
linearly comparable to the long–time limit of the slope of the MSD. When calculating
the diffusion in three dimensions, instead of two as in this study, the integer before
DA becomes 6.
The GROMACS tool gmx msd [153] was used to calculate the MSD of the lipids,
and the diffusion coefficient was determined from the slope of the MSD plotted
as a function of time. Only the linear part of the curve was taken into account
for the calculation of slope. For Martini coarse-grained systems the diffusion has
been reported to be too fast compared to the atomistic systems [163], and thus the
obtained diffusion constant has to be divided by an additional factor of 4. The jumps
of the molecules in the periodic boundaries and the COM motion were removed from
the trajectories for the analysis.
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5. RESULTS AND DISCUSSION
In this chapter the findings regarding the partitioning of β2AR in a highly phase
separable lipid bilayer are presented. A total of 22 coarse-grained MD simulations
were carried out with different starting structures and cholesterol parameters, as
well as two fine grained systems in order to justify the results obtained from coarse-
grained simulations. The systems and their compositions are listed in Table 4.1 and
4.2. The presented graphs have been plotted with MATLAB or directly by the LATEX
platform with PGF/TikZ. Snapshots of the simulated systems have been prepared
with VMD.
5.1 β2AR Partitions to the Lo/Ld Phase Boundary
The phase separation can be followed in time by calculating the fraction of lipid–lipid
contacts, shown in Fig. 5.1(A) for systems R1-R10 with an initially random lipid
distribution around the receptor. Within 4-5 µs the fraction of contacts stabilizes
in each system, indicating that the lipids have found their equilibrium location and
separated into two phases. In systems O1-O5 and D1-D5 the protein was placed
in an already phase separated bilayer. The protein finds its position with respect
to lipids within approximately 3 µs as the fraction of β2AR–DLiPC contacts shows
in Fig. 5.1(B). For each system, the fraction of protein–unsaturated lipid contacts
stabilizes after 3 µs and the fraction stays at a value of ∼0.8. In case the protein
is initially placed in the Lo phase (Fig. 5.1(C)), it takes a longer period of time,
up to 5 µs for stabilization, until the fraction of contacts reaches the value of 0.8.
The fraction of protein–lipid contacts stabilizes within a few µs in systems in which
the protein was initially placed in the Ld phase (Fig. 5.1(D)), also exhibiting a
contact fraction of 0.8 between the protein and unsaturated lipids. The systems
can thus be considered to be stable enough regarding the phase separation and
protein location, when simulated for 10 µs. Notable is that after equilibration the
unsaturated lipids are dominating the protein-lipid contacts with almost 80 % of
lipid contacts, irrespective of the starting configuration.
During the 10 µs simulation of the coarse-grained systems with different starting
structures, β2AR partitions to the phase boundary in each case. Snapshots from the
5.1. β2AR Partitions to the Lo/Ld Phase Boundary 44
0 5 10
0
0.2
0.4
0.6
Fr
ac
ti
on
of
co
nt
ac
ts
A
0 5 10
0
0.5
1 B
0 5 10
0
0.5
1
Time (µs)
Fr
ac
ti
on
of
co
nt
ac
ts
C
0 5 10
0
0.5
1
Time (µs)
D
E Random start Lo start Ld start
t = 0 µs
t = 10µs
Figure 5.1: (A) The fraction of DLiPC-DPPC contacts in systems R1-R10, and the
fraction of β2AR-DLiPC contacts in systems (B) R1-R10, (C) O1-O5, and (D) D1-D5.
Different colors correspond to different systems. E) Snapshots from the beginning of the
simulation (top) and after 10 µs (bottom) in systems R1 (left), O1 (center), and D1 (right).
Color codes in (E) are the same as in Fig. 4.1 and Fig. 4.2.
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beginning and after 10 µs of simulation of systems R1, O1, and D1 are shown in
Fig. 5.1(E) as an example of the β2AR behavior when placed initially in a random
lipid distribution, in the Lo phase, and in the Ld phase. The snapshots after 10 µs
of simulation in all systems establish a similar location for the protein. Even though
β2AR partitions to the phase boundary, in the snapshots after 10 µs it is always
mostly surrounded by polyunsaturated DLiPC lipids. In some cases, as shown after
10 µs in system O1, the Ld phase gets even narrower around the protein, allowing
it to face the phase boundary at both sides. Since the systems are considered stable
after 10 µs of simulation and the protein in each case prefers a similar location,
these results indicate that the protein has found its most preferred location in the
studied membrane.
The lipid distribution between the two phases can be seen in a more quantita-
tive manner by plotting the concentration of lipids along the axis perpendicular
to the phase boundary. The lipid concentrations in the two phases are shown in
Fig. 5.2(A) in system R1 during the last 1 µs of the simulation. The raft–like Lo
domain is composed of 60 % of saturated DPPC, 38 % of cholesterol and 2 % of
unsaturated DLiPC, forming almost a pure binary mixture of saturated lipids and
cholesterol. The mole fraction of cholesterol is even higher than the overall choles-
terol concentration (0.3) in the membrane, and yet below the solubility limit of 0.66
for cholesterol in a DPPC membrane [192]. The Ld domain is composed of 8 %
of DPPC, 14 % of cholesterol, and 78 % of DLiPC. The cholesterol mole fraction
is thus reduced to half of the total cholesterol concentration, showing that the Ld
phase is comparatively cholesterol–poor. The obtained concentrations are similar
to the ones obtained by Risselada and Marrink [145] and in agreement with the
composition of phase separated membranes observed in NMR measurements [59].
The same figure shows the location of the protein COM plotted along the same axis.
The protein preferably stays on the side of the Ld phase, yet not completely in the
center of the phase, but instead close to the phase boundary. The concentration
of lipids and the location of the protein COM along the axis perpendicular to the
phase boundary were similar in each system.
The concentration of lipids at increasing distances from the protein averaged over
different types of systems is plotted in Fig. 5.2(B-D). The concentrations show a
small peak of CHOL at the distance of 1.5 to 2.5 nm. The concentrations closer than
1.5 nm from the β2AR COM show more differences than the concentrations further
from the protein since the amount of lipids within such a short distance from the
protein COM is small. Nevertheless, the most predominant lipid is the unsaturated
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Figure 5.2: (A) The lipid concentration along the axis perpendicular to the lipid phase
boundary in the system R1. The respective plots are similar in all systems, only the
location of the phases changes. The distribution of the protein location is plotted as well
along the same axis. (B,C,D) The concentration of lipids at increasing distances from
β2AR averaged over systems (B) R1-R10, (C) O1-O5, and (D) D1-D5.
DLiPC in each type of system. At distances of 1.5 to 2.5 nm, the DPPC fraction
varies from 0.08 (R1-R10) to 0.18 (O1-O5), the fraction of DLiPC from 0.49 (O1-O5)
to 0.59 (R1-R10 and D1-D5), and the fraction of CHOL from 0.29 (D1-D5) to 0.33
(O1-O5 and R1-R10). The cholesterol concentration close to the protein is similar to
the one in the phase boundary in Fig. 5.2(A), yet the DLiPC concentration is higher
and the DPPC concentration lower compared to the phase boundary concentrations.
The values indicate that β2AR preferentially resides in the phase boundary, slightly
more on the side of the Ld phase, but has a higher concentration of CHOL around
it. This is in line with the findings that have shown β2AR to preferably interacts
with CHOL [16–18].
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5.2 Time Evolution of Lipid Radial Distribution Function from
the β2AR
The time evolution of the DLiPC, DPPC, and CHOL RDFs are plotted in Fig. 5.3
along with the final RDF of all lipids in systems R1, O1, and D1. In the case of
an initially random lipid distribution of system R1, the RDF of DLiPC shows a
clear peak that increases in time, whereas the amount of DPPC close to the protein
decreases in time. The distribution of CHOL is also higher close to the protein COM
during the first two microseconds, but decreases slightly and stabilizes after that,
showing a peak within 2 nm from the protein. When the protein is placed in the Lo
phase in system O1, there are basically no DLiPC molecules close to the protein,
but the distribution near the protein increases rapidly in time and shows a similar
peak as in the case of the system R1. The distributions of DPPC and CHOL are
higher close to the protein COM in the beginning than after 10 µs of simulation,
decreasing within 4 µs to similar curves as in the system R1. The RDFs of lipids
do not vary much in time in the system D1 when the protein is placed in Ld, and
within a few microseconds stabilize to similar distributions as in the final state of
the systems R1 and O1. This implies that the protein is closest to its equilibrium
location with respect to the phases when it is initially placed in the Ld phase.
The radial distributions of lipids from the protein stabilize to similar distributions
within four microseconds in each system, showing similar behavior of the lipids
surrounding the protein irrespective of the starting configuration. The final lipid
distributions show that DLiPC molecules are the dominating ones within 2 nm
from β2AR, only a small amount of CHOL molecules reside closer to β2AR. At the
location of the peak in the DLiPC radial distribution, there is also a smaller peak in
the CHOL distribution. The DPPC molecules are basically all located further than
2 nm from the protein, implying that β2AR is preferably surrounded by unsaturated
DLiPC lipids and cholesterol.
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Figure 5.3: The time evolution of (A-C) DLiPC, (D-F) DPPC, and (G-I) CHOL RDF
in systems R1 (left: A,D,G), O1 (center: B,E,H), and D1 (right: C,F,I). (J-K) The final
RDF of all lipids in the respective systems.
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Figure 5.4: (A-C) The number density of CHOL around β2AR on the intracellular leaflet
of the bilayer and (D-E) on the extracellular leaflet of the bilayer, averaged over systems
(A,D) R1-R10 (B,E), O1-O5, and (C,F) D1-D5.
5.3 β2AR Is Surrounded by Unsaturated Lipids and Choles-
terol
The spatial number density maps of the lipids in the xy-plane averaged over systems
with similar starting configurations are shown in Fig. 5.4, 5.5, and 5.6 for CHOL,
DLiPC, and DPPC, respectively. Four CHOL hot spots are repeated in every type
of system in the intracellular leaflet of the bilayer: first between the helices 1 and
8, second on the surface of the helices 1 and 2, third near the helix 4, and fourth
between the helices 3 and 4. In systems O1-O5 there is a CHOL hot spot on the
surface of the helices 2 and 4 as well that is the location of the CHOL binding
site found in the study of the β2AR crystal structure [18]. The same CHOL hot
spot, although a weaker one, is visible in the intracellular density map averaged
over systems R1-R10, but not in the density map of the systems D1-D5.
The CHOL hot spots on the intracellular leaflet are all located on one side of
β2AR, whereas the hot spots on the extracellular leaflet roughly locate on the op-
posite side of the protein. The surface of the helices 5, 6, and 7 on the extracellular
leaflet are occupied by CHOL in each type of system. Also a hot spot on the surface
of the helix 4 can be seen in systems O1-O5, which is weaker in systems R1-R10
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Figure 5.5: (A-C) The number density of DLiPC around β2AR on the intracellular leaflet
of the bilayer and (D-E) on the extracellular leaflet of the bilayer averaged over systems
(A,D) R1-R10 (B,E), O1-O5, and (C,F) D1-D5.
and D1-D5. The CHOL hot spots on both sides of the bilayer are most prominent
in the systems O1-O5, probably due to the fact that in these systems the protein
is initially placed in the Lo phase enriched with CHOL. However, the hot spots are
visible in all systems, irrespective of the initial configuration, and only small differ-
ences can be seen. The cholesterol hot spots close to the helices 1, 2, and 4 on the
intracellular leaflet correspond to the location of cholesterol observed in the β2AR
crystal structure [16, 18], whereas the hot spots close to the helices 5, 6, and 7 in
the extracellular leaflet are in agreement with cholesterol binding sites suggested for
adenosine receptor A2A receptor, a member of GPCRs [193].
The spatial number density maps of DLiPC do not show such clear spots on the
protein surface as the density maps of CHOL, but instead show almost a shell like
distribution of DLiPC around β2AR. In each type of systems, the shell gets slightly
fainter on the intracellular surface of the helices 1 and 8. Similar density of DLiPC
can be seen in each system.
The spatial distribution of DPPC does not show any remarkable hot spots on
any side of the membrane, in fact, no DPPC molecules seem to locate near the
β2AR surface. There are minor visible spots in the density maps although none of
them are as prominent as the hot spots of DLiPC and CHOL. In all systems there
seems to be a small region preferred by DPPC on the protein surface, located on the
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Figure 5.6: (A-C) The number density of DPPC around the β2AR on the intracellular
leaflet of the bilayer and (D-E) on the extracellular leaflet of the bilayer averaged over
systems (A,D) R1-R10 (B,E), O1-O5, and (C,F) D1-D5.
intracellular surface of the helices 1 and 8. The region is consistent with the fainter
area in the shell of DLiPC and with the location of the two most prominent CHOL
hot spots on the intracellular leaflet.
In Fig. 5.7, 5.8, and 5.9 the lipid occupancy times per protein residue are averaged
over systems with a similar starting configuration and plotted on the protein surface.
There are several regions on the protein surface in contact with CHOL more than
60 % of time, including the intracellular part of the helices 1, 3, 4, 5, and 7, and the
extracellular parts of the helices 2, 6, and 7. Most of these regions can also be seen
as hot spots on the spatial density maps. In accordance with the density maps, the
β2AR surface is covered with regions where DLiPCs are staying more than 60 % of
time, but in contrast only a few regions are in contact with DPPCs. The protein
parts having contacts with DPPC are helix 6, extracellular part of the helix 2, and
the intracellular parts of the helices 3 and 5. These regions are in correspondence
to regions with high CHOL contact, especially helix 6.
The average lipid occupancy time per transmembrane part of each helix is shown
in Fig. 5.10 averaged over each type of system. Each lipid is in contact with DLiPC
the most, and the least with DPPC. On average the transmembrane residues of the
helix 2 are almost 60 % of time in contact with DLiPC and almost 30 % of time
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Figure 5.7: The cholesterol occupancy time on the β2AR surface averaged over systems
(A) R1-R10, (B) O1-O5, and (C) D1-D5.
with CHOL. The regions in which certain lipids tend to stay on the protein surface
differ only slightly, indicating that irrespective of the initial location of the protein
in the membrane, certain lipid types always localize to same regions on the protein
surface. In this case the protein surface is occupied mostly by unsaturated DLiPC
lipids and cholesterol.
For rhodopsin and opsin, other members of the GPCR superfamily, the polyunsat-
urated lipid chains were found as well packed against the surface of the protein [21].
Calculation of density maps and radial distribution of lipids yielded consistent re-
sults. In addition to the shell of polyunsaturated lipids surrounding the receptors,
also few cholesterol hot spots were found. Polyunsaturated lipid chains have been
found in high concentrations on the rhodopsin surface as well in other studies in-
volving experiments and simulations [194–196]. This preference was suggested to be
entropically driven [196].
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Figure 5.8: The DLiPC occupancy time on the β2AR surface averaged over systems (A)
R1-R10, (B) O1-O5, and (C) D1-D5.
Figure 5.9: The DPPC occupancy time on the β2AR surface averaged over systems (A)
R1-R10, (B) O1-O5, and (C) D1-D5.
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Figure 5.10: The lipid occupancy time per TM helix averaged over systems (A) R1-R10
(B) O1-O5, and (C) D1-D5.
5.4 Similar Phase Behaviour of β2AR with Different Choles-
terol Parameters
In the current Thesis, to check the validity of our results, we used two different
cholesterol parameters, the one of Melo, Ingólfsson, and Marrink [172] and the one
of Daily et al. [171]. The order parameters (Fig. 5.11(A-D)) and the diffusion coef-
ficients (Fig. 5.11(E)) of the two coarse-grained PC lipids are quite different due to
the different properties of the two phases. The diffusion coefficient of DLiPC varies
between 4.4×10−8 cm2/s and 5.1 ×10−8 cm2/s in the systems R1-R10, O1-O5, and
D1-D5 using the Martini CHOL parameter of Melo, Ingólfsson, and Marrink, and in
the systems RC1 and RC2 with the CHOL parameter of Daily et al., the coefficient
is 6.4·10−8 cm2/s. The diffusion coefficients of DPPC are between 1.6·10−8 cm2/s
and 1.7·10−8 cm2/s in the systems R1-R10, O1-O5, and D1-D5, and 0.8·10−8 cm2/s
in the systems RC1-RC2. The diffusion of lipids in the Lo phase is much slower than
in the Ld phase.
The diffusion of lipids in the Lo phase is slower with the CHOL parameter of
Daily et al. than with the one of Melo, Ingólfsson, and Marrink. The Lo phase is
also more ordered, similar to the old Martini cholesterol [158,177,178]. The lipids in
the Ld phase have a higher diffusion coefficient in systems RC1-RC2, and are thus
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moving faster than with the CHOL parameter of Melo, Ingólfsson, and Marrink, but
the order of the Ld phase is similar. A higher amount of cholesterol is located in the
Lo phase than in the Ld phase, which causes a bigger influence in the order of the
Lo phase comprising lipids when the cholesterol parameter is changed.
Even though the properties of the Lo and Ld phases differ when changing the
CHOL parameter, the interaction of lipids with β2AR is similar with both CHOL
parameters used. The final RDF of lipids from the protein in the system RC2
(Fig. 5.11(F)) shows a similar distribution, and the number density of lipids gives
a similar distribution of hot spots around the protein as the ones with the CHOL
parameter of Melo, Ingólfsson, and Marrink. Also the lipid occupancy time averaged
per transmembrane helix, shown in Fig. 5.11(G), gives similar preferences of lipids
for certain helices of β2AR as with the first parameter.
The CHOL parameter of Daily et al. has been developed to better match the
properties of cholesterol in atomistic simulations. Yet, the effect of this cholesterol
parameter in the behavior of the phase segregated membrane is similar to the effect
of the previous Martini coarse-grained cholesterol parameter [158], that has been
reported to cause the Lo phase to be too ordered [177, 178]. The Martini CHOL
parameter of Melo, Ingólfsson, and Marrink used in 20 systems in this study better
characterizes the phase behavior of the lipids than the parameter of Daily et al. that
was used in two of the systems. Both of the parameters, however, exhibit similar
behavior between the lipids and β2AR.
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Figure 5.11: (A-D) The order parameters of the Martini coarse-grained PC lipid chains
(A) DLiPC chain 1, (B) DLiPC chain 2, (C) DPPC chain 1, and (D) DPPC chain 2,
averaged over the systems R1-R10, O1-O5, D1-D5, and RC1-RC2. Errors are less than
0.01. (E) The diffusion coefficients of the PC lipids fitted to the MSD curve averaged over
the systems R1-R10, O1-O5, D1-D5, and RC1-RC2. (F) The radial distribution of lipids
from the protein during the last 2 µs simulation in system RC2. (G) The lipid occupancy
time per TM helix averaged over systems RC1-RC2.
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5.5 β2AR Prefers a Thinner and Less Ordered Local Mem-
brane
In Fig. 5.12(A-D) the two-dimensional thickness averaged over each type of system
is shown. The membrane thickness surrounding β2AR is mainly between 39 and 40
Å in each type of system. The thickness corresponds to the membrane thickness in
the Ld phase, while the Lo phase is thicker, up to 44 Å. Yet there are two regions
repeated in the 2D thickness plot of each system type in which the bilayer is thicker
than in the Ld phase, almost 41 to 42 Å. These regions are located close to the helices
1 and 8, and the helices 3, 4, and 5. Cholesterol number density showed hot spots
present in this area, which might induce the membrane thickness at these locations.
The hydrophobic thickness of the membrane in the Lo/Ld boundary might match
the hydrophobic parts of the protein and this could be one of the reasons for the
protein to localize to the phase boundary. It seems that the protein creates a special
thickness environment around it, with slightly varying thicknesses.
The lipid chain order parameter averaged over all the systems is shown in
Fig. 5.12(E-F). The protein seems to prefer a less ordered membrane around it.
The two thicker regions surrounding the protein, visible in the 2D thickness plots,
are not that clearly repeated in the membrane order plots. It has been postulated
that the lipid type surrounding the protein might define its affinity for domains con-
sisting of lipids compatible with the lipids surrounding the protein [82]. Since the
protein is surrounded by a more disordered membrane, the protein might therefore
end up to the side of the Ld domain in the phase boundary. However, it is obvious
that the β2AR prefers a thinner membrane and less ordered lipid chains around it
than in the Lo phase, and seems to create a special environment of slightly varying
properties around it.
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Figure 5.12: (A) A 3D distribution of the bilayer thickness averaged over systems R1-
R10. (B-D) 2D thickness and (E-G) lipid order parameter averaged over systems (B,E)
R1-R10, (C,F) O1-O5, and (D,G) D1-D5.
5.6 Atomistic Systems Show Similar Properties as Coarse-
Grained Systems
The systems B1 and B2 were backmapped from a coarse-grained to an all-atom
description and their simulations were started from configurations in which the pro-
tein was in the Lo/Ld phase boundary (system B1) or completely in the Ld phase
(system B2). In Fig. 5.13, the initial configurations of the systems B1 and B2 are
shown along with the configurations after 2 µs simulation. In the system B1, the
protein is in the phase boundary, and during the simulation the few saturated DPPC
molecules on its surface are replaced by unsaturated DOPC and CHOL molecules,
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Figure 5.13: Snapshots from the beginning and after 2 µs simulation of (A) the intra-
cellular side of the system B1 and (B) the extracellular side of the system B2. The color
codes are similar to Fig. 4.1 and Fig. 4.2. The protein helices are marked with white labels
next to the helices.
although saturated lipids remain close to the helices 1, 7, and 8. The system B2
is completely surrounded by the Ld phase in the beginning of the simulation, and
remains there, but in addition some saturated lipids move close to the helices 1,
2, 4, and 7. In these locations the membrane was found slightly thicker compared
to the total membrane surrounding the protein in the coarse-grained simulations
(Fig. 5.12).
The fraction of lipid-lipid and protein-lipid contacts in the systems B1 and B2 are
plotted in Fig. 5.14(A-B). The lipid-lipid and protein-lipid contact fraction curves
are similar to the ones obtained in coarse-grained systems, although it seems that
especially the protein-lipid contact fraction in system B2 is not stabilized within
the 2 µs simulation. However, the simulations are very short compared to the
coarse-grained simulations, and the contact fraction curves are fluctuating within
reasonable limits if compared to the curves in coarse-grained simulations during the
same time interval.
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Figure 5.14: (A) The fraction of lipid-lipid contacts, and (B) the fraction of protein-lipid
contacts in the atomistic systems B1 and B2. The lipid composition versus distance from
the protein calculated from the last 1 µs trajectory of the systems (C) B1 and (D) B2.
The lipid composition close to the protein (Fig. 5.14(C-D)) is similar to the
coarse-grained systems at a distance of 1.5-2.5 nm. The unsaturated lipids are
the dominating ones along with a faint peak in the cholesterol concentration, while
the saturated lipids are excluded from the protein surface. The cholesterol concen-
tration remains similar to the coarse-grained systems, around 30 %, yet the unsat-
urated DOPC lipid concentration is higher, close to 70 %, whereas the saturated
DPPC concentration stays very low, less than 10 %.
It should be noted that the analysis results from the two atomistic systems are
only single repetitions, whereas the results from the coarse-grained systems have
been averaged over many systems with longer simulation times. Additionally, the
protein partitioning from similar starting configurations as in the coarse-grained
systems is quite challenging with the current atom-scale computing limits, for which
reason the systems were started near the assumed protein equilibrium location.
However, the 2 µs simulation of atomistic systems is enough for the protein to
slightly stabilize its surroundings, and no dramatic changes are seen, which indicates
that the obtained environment is appropriate for the protein also in the atomistic
model.
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6. CONCLUSIONS
The aim of this Thesis was to find out the preference of the β2–adrenergic receptor, a
characteristic member of the GPCRs, for different membrane domains in a laterally
phase segregated membrane. Many components important in the cAMP pathway,
such as GPCRs and G proteins, have been suggested to localize to caveolae and rafts
that would enable rapid activation of signaling pathways [10,54,58,132,133]. β1AR
and β2AR have been found to localize in caveolae, but whereas β1AR continually
stays there, β2AR was found to translocate out of the caveolae upon activation [11].
The β2AR partitioning into domains has not been studied either by simulations or
membrane vesicle studies, although such studies for rhodopsin show partitioning
to the Ld domain [19, 20]. Additionally, some simulation studies of rhodopsin and
opsin, other GPCRs, show preference for unsaturated lipid chains on the receptor
surface [21]. These studies would support the partitioning of β2AR, a receptor
reminiscent to rhodopsin, to the Ld phase. However, β2AR is also widely associated
to cholesterol [16–18], which on the other hand could lead to the association of the
receptor to the cholesterol-enriched Lo domain.
The problem was approached by computational molecular dynamics simulations
using both the coarse-grained Martini force field and the all-atom OPLS force field
for the simulated lipids and the receptor protein. In total, 22 coarse-grained sys-
tems were built in which the inactive β2AR was placed in different locations; ten
systems with the protein initially in a random lipid distribution, and ten systems
with a completely phase segregated bilayer in which the protein was placed in the
Lo phase (five systems) or in the Ld phase (five systems), and two systems in which
another coarse-grained cholesterol model was tested. The two atomistic systems
were backmapped from the coarse-grained systems in order to validate the results
obtained by the coarse-grained simulations; in one system the protein was com-
pletely in the Ld phase surrounded by unsaturated lipids, and in the other system
the protein was at the boundary of the two phases.
The results obtained from the simulations all supported the idea of β2AR par-
titioning to the Ld domain, however instead of being completely embedded to the
domain, the protein was found to reside at the boundary of the two phases, though
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most of the time surrounded by unsaturated lipids. Both concentration and radial
distribution function of lipids showed a peak close to the protein in the distribution
of the unsaturated lipids and cholesterol, while saturated lipids were in all cases
staying further away from the protein. Notable is that the results obtained from
all simulations were similar, irrespective of the location in which the protein was
initially placed, which implies that the protein found its equilibrium location during
the simulation time in each system.
The density maps of lipids, the local membrane thickness, and the local lipid
chain order parameter all indicated that β2AR creates a special lipid environment
around it. The local membrane around the protein comprised a shell of unsaturated
lipids and hot spots of cholesterol. The surrounding lipid environment was very
similar to the ones obtained for rhodopsin and opsin [21, 194–196]. The protein
was also residing in a less thicker and less ordered membrane environment than the
Lo phase. The membrane surrounding the protein was not completely uniform in
thickness, but included a few locations with higher thickness. These locations were
in accordance with the cholesterol hot spots, which might lead to the thickening of
the membrane.
The results obtained from the atomistic systems were in accordance with the
ones obtained from the coarse-grained systems. Due to computational limits, the
atomistic systems were started from the configuration in which the protein was
close to the assumed equilibrium location. In order to better justify the surrounding
environment preferred by β2AR, another atomistic system will be built in which the
protein will be placed in a random lipid distribution. Even though the time scale of
lipid phase separation is unreachable, the lipid-protein environment should stabilize
within a few microseconds.
There might be several reasons for the β2AR partitioning into the Lo/Ld phase
boundary. Transmembrane proteins can alter the surrounding membrane properties
up to 3-4 nm distance away from the protein surface [83]. For lower free energy
cost, the membrane and the protein always tend to organize in such a way that the
hydrophobic thickness of the membrane matches with the hydrophobic regions of
the protein [84–88]. This might be one factor affecting the protein location, however
it has been shown that the hydrophobic thickness can not be the only driving force
in the protein segregation to the domains [146, 197]. Another suggestion would be
the membrane diffusion rate matching the protein diffusion in that area. It has also
been suggested that the lipids surrounding the transmembrane protein might define
its affinity for domains composed of lipids compatible with ones surrounding the
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protein [82]. This theory would explain the protein preference for the Ld domain
composed of unsaturated lipids that create the shell around the protein. On the other
hand, the protein does not completely stay in the Ld domain, but at the boundary of
the two domains. The results indicate that several cholesterol molecules also reside
on the protein surface and that the cholesterol concentration around the protein is
close to the concentration of the Lo phase, which might drag the protein towards
the Lo phase enriched with cholesterol. The affinity for two domains might result in
the protein staying in the boundary of the two phases. The reason for the protein
staying on the side of the Ld phase at the boundary might be in its preference for
the unsaturated lipids chains [21, 194–196].
The results obtained in this study are consistent with the ones obtained for
rhodopsin, which was found in simulations and giant vesicle studies to reside in
the Ld phase [19, 20]. In addition to residing mostly in the Ld phase, this study is
the first one to show that β2AR creates its own environment at the boundary of the
two phases. Meanwhile, the results are not consistent with the suggestion of the
β2AR residing in the Lo domain in an inactive state, at least with this molecular
model [11]. There are other factors as well that might affect the protein partition-
ing, such as glycosylation and palmitoylation [90], which could be applied to see if
the β2AR preference for the surrounding lipids and for the location with respect to
the phases would change. Since activity–dependent partitioning of β2AR has been
suggested [11], and also the active, Gs protein bound structure of β2AR has been
discovered, similar computational studies involving the active structure with and/or
without the bound G protein could be carried out to investigate this hypothesis.
Combining experimental studies of the β2AR partitioning in for example phase seg-
regated giant vesicles, as for rhodopsin [19], would bring new insights to the matter.
In the future, along with increasing computational capacity, the time scales of recep-
tor partitioning in a phase segregated membrane could even be reachable for atomic
scale systems.
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APPENDIX A. CONCENTRATION OF LIPIDS IN
THE PHASE SEGREGATED MEMBRANE
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Figure A.1: The lipid concentration along the axis perpendicular to the lipid phase
boundary in the systems (A-J) R1-R10 and (K-L) RC1-RC2.
APPENDIX A. Concentration of Lipids in the Phase Segregated Membrane 79
0 10 20
0
0.5
1
C
on
ce
nt
ra
ti
on
A
0 10 20
0
0.5
1 B
0 10 20
0
0.5
1
Distance (nm)
C
0 10 20
0
0.5
1
Distance (nm)
C
on
ce
nt
ra
ti
on
D
0 10 20
0
0.5
1
Distance (nm)
E
0 10 20
0
0.5
1
C
on
ce
nt
ra
ti
on
F
0 10 20
0
0.5
1 G
0 10 20
0
0.5
1 H
0 10 20
0
0.5
1
Distance (nm)
C
on
ce
nt
ra
ti
on
I
0 10 20
0
0.5
1
Distance (nm)
J DPPC
DLiPC
CHOL
B2AR
Figure A.2: The lipid concentration along the axis perpendicular to the lipid phase
boundary in the systems (A-E) O1-O5 and (F-J) D1-D5.
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APPENDIX B. CONCENTRATION OF LIPIDS
AT INCREASING DISTANCES FROM THE
PROTEIN
0 5 10
0
0.2
0.4
0.6
0.8
C
on
ce
nt
ra
ti
on
A
0 5 10
0
0.2
0.4
0.6
0.8
B
0 5 10
0
0.2
0.4
0.6
0.8
C DPPC
DLiPC
CHOL
0 5 10
0
0.2
0.4
0.6
0.8
C
on
ce
nt
ra
ti
on
D
0 5 10
0
0.2
0.4
0.6
0.8
E
0 5 10
0
0.2
0.4
0.6
0.8
F
0 5 10
0
0.2
0.4
0.6
0.8
C
on
ce
nt
ra
ti
on
G
0 5 10
0
0.2
0.4
0.6
0.8
H
0 5 10
0
0.2
0.4
0.6
0.8
I
0 5 10
0
0.2
0.4
0.6
0.8
Distance (nm)
C
on
ce
nt
ra
ti
on
J
0 5 10
0
0.2
0.4
0.6
0.8
Distance (nm)
K
0 5 10
0
0.2
0.4
0.6
0.8
Distance (nm)
L
Figure B.1: The lipid concentration at distances [0..1.5,1.5..2.0,2.0..2.5,...,9.5..10] from
protein in the systems (A-J) R1-R10 and (K-L) RC1-RC2.
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Figure B.2: The lipid concentration at distances [0..1.5,1.5..2.0,2.0..2.5,...,9.5..10] from
protein in the systems (A-E) O1-O5 and (F-J) D1-D5.
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Figure C.1: The final RDF of lipids in the systems (A-J) R1-R10 and (K-L) RC1-RC2.
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Figure C.2: The final RDF of lipids in the systems (A-E) O1-O5 and (F-J) D1-D5.
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APPENDIX D. DIFFUSION COEFFICIENTS OF
LIPIDS
Table D.1: The diffusion coefficients of the PC lipids fitted to the MSD curve calculated
from the last 5 µs trajectory of each system.
DLiPC DPPC
System D (1e-8 cm2/s) Error D (1e-8 cm2/s) Error
R1 4.24 0.01 1.81 0.01
R2 4.44 0.03 1.76 0.01
R3 4.63 0.01 1.52 0.01
R4 4.51 0.02 1.79 0.01
R5 5.46 0.02 1.68 0.01
R6 4.49 0.01 1.79 0.01
R7 4.56 0.01 1.88 0.01
R8 4.63 0.01 1.59 0.01
R9 3.28 0.01 1.76 0.01
R10 3.94 0.02 1.63 0.01
Mean & av.dev. 4.42 0.55 1.72 0.12
RC1 6.83 0.02 0.78 0.01
RC2 5.99 0.01 0.79 0.01
Mean & av.dev. 6.41 0.59 0.79 0.01
O1 5.28 0.02 1.50 0.01
O2 5.12 0.01 1.63 0.01
O3 4.53 0.01 1.63 0.01
O4 5.78 0.01 1.68 0.01
O5 5.03 0.01 1.72 0.01
Mean & av.dev. 5.15 0.45 1.63 0.09
D1 4.98 0.02 1.55 0.01
D2 4.86 0.02 1.67 0.01
D3 4.85 0.02 1.75 0.01
D4 5.63 0.02 1.79 0.01
D5 3.86 0.02 1.56 0.01
Mean & av.dev. 4.84 0.64 1.66 0.11
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APPENDIX E. LIPID DENSITY MAPS AND
NUMBER OF CONTACTS IN SYSTEMS
RC1–RC2
Figure E.1: The number density of (A) CHOL, (B) DLiPC, and (C) DPPC on the
intracellular leaflet of the bilayer and (D-E) on the extracellular leaflet of the bilayer
respectively, averaged over of systems RC1-RC2.
Figure E.2: The lipid occupancy time of (A) CHOL, (B) DLiPC, and (C) DPPC on the
β2AR surface averaged over systems RC1-RC2.
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APPENDIX F. TWO-DIMENSIONAL
THICKNESS AND LIPID CHAIN ORDER
PARAMETER
Figure F.1: The two-dimensional bilayer thickness in systems (A-J) R1-R10 and (K-L)
RC1-RC2.
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Figure F.2: The two-dimensional bilayer thickness in systems (A-E) O1-O5.
Figure F.3: The two-dimensional bilayer thickness in systems (A-E) D1-D5.
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Figure F.4: The two-dimensional lipid chain order parameter in systems (A-J) R1-R10
and (K-L) RC1-RC2.
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Figure F.5: The two-dimensional lipid chain order parameter in systems (A-E) O1-O5.
Figure F.6: The two-dimensional lipid chain order parameter in systems (A-E) D1-D5.
